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ABSTRACT
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Patient recruitment and enrollment are critical factors for a successful clinical
trial; however, recruitment tends to be the most common problem in most clinical trials.
The success of a clinical trial depends on efficiently recruiting suitable patients to
conduct the trial. Every clinical trial research has a protocol, which describes what will be
done in the study and how it will be conducted. Also, the protocol ensures the safety of
the trial subjects and the integrity of the data collected. The eligibility criteria section of
clinical trial protocols is important because it specifies the necessary conditions that
participants have to satisfy.
Since clinical trial eligibility criteria are usually written in free text form, they are
not computer interpretable. To automate the analysis of the eligibility criteria, it is
therefore necessary to transform those criteria into a computer-interpretable format.
Unstructured format of eligibility criteria additionally create search efficiency issues.
Thus, searching and selecting appropriate clinical trials for a patient from relatively large
number of available trials is a complex task.
ii

A few attempts have been made to automate the matching process between
patients and clinical trials. However, those attempts have not fully integrated the entire
matching process and have not exploited the state-of-the-art Natural Language Processing
(NLP) techniques that may improve the matching performance. Given the importance of
patient recruitment in clinical trial research, the objective of this research is to automate
the matching process using NLP and text mining techniques and, thereby, improve the
efficiency and effectiveness of the recruitment process.
This dissertation research, which comprises three essays, investigates the issues of
clinical trial subject recruitment using state-of-the-art NLP and text mining techniques.

Essay 1: Building a Domain-Specific Lexicon for Clinical Trial Subject Eligibility
Analysis
Essay 2: Clustering Clinical Trials Using Semantic-Based Feature Expansion
Essay 3: An Automatic Matching Process of Clinical Trial Subject Recruitment

In essay1, I develop a domain-specific lexicon for n-gram Named Entity
Recognition (NER) in the breast cancer domain. The domain-specific dictionary is used
for selection and reduction of n-gram features in clustering in eassy2. The domainspecific dictionary was evaluated by comparing it with Systematized Nomenclature of
Medicine--Clinical Terms (SNOMED CT). The results showed that it add significant
number of new terms which is very useful in effective natural language processing In
essay 2, I explore the clustering of similar clinical trials using the domain-specific lexicon
and term expansion using synonym from the Unified Medical Language System (UMLS).

iii

I generate word n-gram features and modify the features with the domain-specific
dictionary matching process. In order to resolve semantic ambiguity, a semantic-based
feature expansion technique using UMLS is applied. A hierarchical agglomerative
clustering algorithm is used to generate clinical trial clusters. The focus is on
summarization of clinical trial information in order to enhance trial search efficiency.
Finally, in essay 3, I investigate an automatic matching process of clinical trial clusters
and patient medical records. The patient records collected from a prior study were used to
test our approach. The patient records were pre-processed by tokenization and
lemmatization. The pre-processed patient information were then further enhanced by
matching with breast cancer custom dictionary described in essay 1 and semantic feature
expansion using UMLS Metathesaurus. Finally, I matched the patient record with clinical
trial clusters to select the best matched cluster(s) and then with trials within the clusters.
The matching results were evaluated by internal expert as well as external medical expert.
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CHAPTER 1
INTRODUCTION

"Never before in history has innovation offered
promise of so much to so many in so short a time."
Bill Gates

Basic science research has flourished over the past few decades and transferred
knowledge into dramatic scientific advances for the treatment and prevention of human
disease. As a result of these advances, new therapeutic agents, procedures, and devices
have appeared. The healthcare industry has experienced decades of growth and success
(Nussenblatt and Meinert, 2010).
Ever since the evidence-based practice was adopted, efforts have increased to
base medical care as much as possible on the evidence of scientific research rather than
on expert opinion or personal experience (National Research Council, 2001). A scientific
experiment that provides one of the least biased type of clinical research evidence is the
randomized controlled trial (RCT) (Sim et al., 2004). Moreover, RCTs are the most
rigorous way to decide the existence of a cause-effect relationship between treatment and
outcome (Sibbald and Ronalrd, 1998). In this sense, RCTs help to move basic scientific
research from the laboratory into treatment for humans.
An RCT is also called a randomized clinical trial when it is applied to clinical
research (Peto et al., 1976). A clinical trial is defined as “Research studies that explore
whether a medical strategy, treatment, or device is safe and effective for humans”
(National Institutes of Health, http://www.nhlbi.nih.gov/health/health-
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topics/topics/clinicaltrials/). The main objective of a clinical trial is to evaluate the
efficacy and / or effectiveness of a medical intervention with human subjects. Thus, new
treatment can be proven safe and effective before public deployment. Cautiously
conducted clinical trials are considered the fastest and safest way to find new treatments
(NLM, http://www.nlm.nih.gov/medlineplus/tutorials/clinicaltrials/).
It is clear that a clinical trial is one of most important resources of practical
medical knowledge. Over the past decade, the total number of clinical studies registered
on ClinicalTrials.gov, based on the First Received Date, has dramatically increased
(Figure 1). ClinicalTrials.gov, run by the U.S. National Library of Medicine (NLM), is
the official public registry of clinical trials. To date (as of July, 2015), there were more
than 190,000 trials for about 5,000 diseases on ClinicalTrials.gov (ClinicalTrials.gov).

Figure 1. Number of Registered Studies
(ClinicalTrials.gov, 2015)
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Patient recruitment and enrollment are critical factors for successful clinical trial
research (Fran, 2004), and it is well known that subject recruitment is the most common
problem in most clinical trials (Ashery and Mcauliffe, 1992). Inadequate recruitment can
disrupt a clinical trial research timetable, waste resources, reduce the trial’s ability to
detect treatment effectiveness, and perhaps result in the failure of a clinical trial research
project (Ashery and Mcauliffe, 1992). Accordingly, it is essential to achieve clinical trial
research participant enrollment to conduct a successful trial (Frank, 2004).
In other words, the success of a clinical trial depends on efficiently recruiting
suitable patients to conduct the trial. Insufficient patient participation from the time of a
study’s initiation to closeout might incur lack of statistical power to prove or disprove the
goal of the clinical trial research (Frank, 2004). The main cause of recruitment problems
includes the need for large samples and multiple eligibility criteria, subject reluctance,
low patient treatment motivation, client dislike of research procedures, clinicians’ distrust
of research, and difficulties collaborating with treatment agencies.
Like other scientific research, every clinical research has a protocol that describes
what will be done in the study and how it will be conducted. Also, the protocol ensures
the safety of the trial subjects and integrity of the data collected. For this reason, it is a
critical document for everyone involved in conducting the trial. In particular, the protocol
of clinical trials should be followed precisely, since they deal with human subjects. In the
U.S., diverse organizations, including the Office of Human Subjects Research Protection
(OHRP) and the Food and Drug Administration (FDA), have the authority to determine
whether certain clinical studies are adequately conducted according to their protocols.
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The eligibility criteria section of clinical trial protocols is important because it
specifies the necessary conditions of clinical research participants (Luo et al., 2011).
According to the definition from the U.S. National Library of Medicine (U.S. NLM,
ClinicalTrials.gov), eligibility criteria for clinical trials are “the medical or social
standards determining whether a person may or may not be allowed to enter a clinical
trial; they are based on such factors as age, gender, the type and stage of a disease,
previous treatment history, and other medical conditions.”
Since clinical research eligibility criteria are usually written in free text form, they
are not computer interpretable. A popular method for achieving computable eligibility
criteria is knowledge representation, which often requires labor-intensive manual effort
and medical expert encoders in identifying the semantics of the eligibility criteria (Luo et
al. 2010; Samson et al. 2011). No one can deny that standard-based formal computer
understandable representation of eligibility criteria would provide obvious benefits for
supporting clinical research and care use cases (Ross et al. 2010; Weng et al 2010).
Therefore, the necessity for transforming free text eligibility criteria into a computable
format has increased. In the last few years, a considerable number of attempts have been
made at formal representations of eligibility criteria (Samson et al. 2011; Luo et al. 2010;
Luo et al. 2010; Weng et al. 2010; Ross et al. 2010; Luo et al. 2013).
Unstructured characteristics of eligibility criteria raise other issues for search
efficiency. It is not a simple task for a patient to search a huge repository and select
appropriate clinical trials because subject eligibility criteria are not in a structured form
but in free text form. The results from existing trial search engines usually are not
satisfactory and require a manual process to refine relevant studies (Boland et al. 2013).
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Boland et al. (2013) proposed feature-based indexing, clustering, and search of clinical
trials, but their work still depends on a manual process by an expert for selection
eligibility criteria features. To the best of my knowledge, no attempts have so far been
made to build an entire automatic matching process for clinical trial clusters and patient
information using state of art NLP and text mining algorithms. Given the importance of
patient recruitment in clinical trial research, the objective of this dissertation is to build an
integrated automatic matching process for clinical trials and patient information that
enhances efficiency and effectiveness of the clinical trial subject recruitment process by
using a NLP and Text Mining technique.
Essay 1 examines the building of a breast cancer domain-specific lexicon for ngram Named Entity Recognition (NER). The domain-specific dictionary is used for
selection and reduction of word n-gram features in the clinical trial clustering and
matching patients to clusters and clinical trials. Essay 2 explores clustering of similar
clinical trials using the domain-specific lexicon built in Essay1 and a synonym
relationship from the Unified Medical Language System (UMLS). I generated word ngram features and modified the features with the domain-specific dictionary matching
process. In order to resolve semantic ambiguity, all synonym tags from the UMLS are
annotated to the original features. A hierarchical agglomerative clustering (HAC)
algorithm is used to generate clinical trial clusters. The focus of essay 2 is to examine the
summarization of clinical trial information at cluster level to enhance trial search
efficiency. Finally, essay 3 investigates an automatic matching process for patient
information with clinical trial clusters and clinical trials within matched clusters.

6

Figure 2. Steps in Patient and Clinical Trial Matching
Using a Domain Specific Dictionary and UMLS Synonyms

Figure 2 shows all the research steps included in essays 1, 2, and 3.
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Essay 1: Building a Domain-Specific Lexicon for Clinical Trial Subject Eligibility
Analysis
It is well understood that an NLP application requires sophisticated lexical
resources to support its processing goals. Different solutions have been proposed to
identify multi-gram disease named entities in the healthcare informatics literature. Jimeno
et al. (2008) found that dictionary look-up provides competitive results with statistical
approach and MetaMap solution, indicating that the use of disease terminology is highly
standardized throughout the terminologies and the literature. Although there has been
extensive effort made in the identification of protein- and gene-named entities (PGNs) in
the biomedical literature, little research has been done on the recognition and resolution
of terminologies in the clinical trial subject eligibility analysis.
A lexicon plays a significant role in all forms of medical language processing
(Luo et al., 2010). At present, there is no comprehensive lexicon to capture multi-gram
medical terminology in clinical trial eligibility criteria, especially in the breast cancer
domain.
The goal of essay 1 is to build a breast cancer specific lexicon to cover clinical
trial eligibility criteria and complete the multi-gram medical terminology.

Essay 2: Clustering Clinical Trials Using Semantic-Based Feature Expansion
With so much data and information around us, it becomes a problem to find
pieces that are relevant. Therefore, a great deal of effort has been made to reduce the
clinical trial search space. However, most of the proposed solutions require users to
understand data structure and to generate complex database queries. The need for
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understanding various medical terminologies remains an unsettled issue. The Unified
Medical Language System® (UMLS®) was initiated and is now being maintained by
The National Library of Medicine (NLM). The objective of UMLS is to facilitate the
development of computer systems that deal with the semantics of the language of
biomedicine and healthcare. In essay 2, I propose a novel clustering method to narrow the
clinical trial search space using a custom dictionary and the UMLS Semantic Network.

Essay 3: An Automatic Matching Process for Clinical Trial Subject Recruitment
The process of new treatment and new drug development is extremely time
consuming and expensive. A key bottleneck in this process is subject recruitment in
clinical trials. Of all clinical trials conducted globally, more than 80% are delayed due to
slow patient recruitment. This delay may cost the pharmaceutical companies millions of
dollars per day in terms of lost sales. Speeding up patient recruitment in clinical trials can
result in lower drug development costs and, ultimately, new drugs that are more
affordable to patients.
In essay 3, I propose a novel automatic matching process of clinical trials and
patient medical records. First, patient records were collected from a prior study and were
pre-processed for tokenization and lemmatization. Second, the pre-processed patient
records were matched with breast cancer custom dictionary and UMLS Metathesaurus for
semantic feature expansion. Finally, I compared each pre-processed patient record with
clinical trial clusters and each clinical trial study within matched clusters. The matching
results are evaluated by internal expert as well as external medical expert.
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CHAPTER 2
Essay 1: Building a Domain-Specific Lexicon for
Clinical Trial Subject Eligibility Analysis
“Not everything that can be counted counts
and not everything that counts can be counted”

Albert Einstein

2.1. Introduction
There is a growing number of healthcare-related corpora and document data in the
free text form, and with this comes the need to analyze and draw meaningful information.
However, it is not easy to retrieve and query relevant information from text data. There
have been several attempts at applying NLP and text mining techniques to the healthcare
domain.
Clinical trials are designed to answer specific questions about the effects of a
therapy or technique designed to improve human health. They rely on eligibility criteria,
which specify who is qualified for clinical research study participation and who is
disqualified. However, analysis of clinical trial subject eligibility text is not a typical text
analysis task since it has some intriguing characteristics. In particular, the clinical trial
subject eligibility section comprises a variety of biomedical terms that include
abbreviations and acronyms. Moreover, clinical trial subject eligibility texts are not
usually complete syntactically. They are not depicted by complete sentences, but outlined
by succinct and fragmented phrases. For example, a sentence in the inclusion criteria of
the clinical trial id ‘NCT01068483’ is ‘Progressive, recurrent unresectable disease’ which
is not a grammatically complete sentence.
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There is an increasing need to efficiently transform these free text clinical
research eligibility criteria into computable formats to support the subject recruitment
process. Various approaches have been proposed to achieve high-performance text
analysis of clinical trial subject eligibility criteria. Prior work has typically used the Bag
of Words (BOW) model as features for text analysis. However, the BOW approach does
not recognize multi-word terms, which are typical in medical and healthcare domains.
The term dependency is the issue in the general BOW approach. The n-gram
model takes into consideration the context information of a word, which depends on a
previous or next word (Khan, 2010). But while the n-gram model improves the text
analysis performance, it decreases the performance if the word length of n is greater than
3 (Liu, 2008).
A lexicon is fundamental to all forms of medical language processing and plays a
significant role (Lou et al. 2010). Dictionary-based n-gram features induction, in which
only those n-grams that appear in a pre-defined dictionary are used as features (Remus
and Rill, 2013). The n-gram feature induction approach yields the most accurate
discriminative model for machine learning-based text analysis within a specific domain.
Moreover, the dictionary-based n-gram feature induction leads to large dimensionality
reductions. Thus, this feature selection may significantly reduce both noise and feature
space size.
At present, there is no lexicon resource for identifying the n-gram terms in breast
cancer clinical trial eligibility. In this essay, I build a domain-specific lexicon to facilitate
analysis of a breast cancer clinical trial subject eligibility section. To the best of my
knowledge, such a study has not been carried out before.
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This essay is structured as follows. The next section reviews prior research in
lexicon-building. In section 2.3, I describe short representations of textual documents,
term frequency, inverse document frequency, data-driven n-gram feature induction, and
the dictionary-based word n-gram feature induction approach. In section 2.4, the n-gram
lexicon building process is described, and I compare the proposed lexicon and UMLS to
evaluate its effectiveness in section 2.5. Finally, I draw conclusions and point out
possible directions for future work in section 2.6.

2.2. Background Literature
Over the past few years, there have been several studies on clinical trials that use
the text mining approach. One of the salient research streams is formal representation of
eligibility criteria (Weng et al. 2009). Tu et al (2011) examined formalizing eligibility
criteria in a computer-interpretable language to facilitate eligibility determination for
study subjects and the identification of studies on similar patient populations. ERGO
(Eligibility Rule Grammar and Ontology) annotation is used for capturing the semantics
of criteria. Luo et al. (2013) examined a semi-automatic process to extract Common Data
Elements (CDEs) in eligibility criteria of clinical trials. Luo et al. (2013)’s study is the
first study using text mining in CDE discovery from free text clinical trial eligibility
criteria.
There have been foundational studies on enhancing eligibility criteria
representation. Luo et al. (2010) presented a corpus-based approach to create a semantic
lexicon for clinical research eligibility criteria using UMLS. The main purpose of that
research was to reduce the ambiguity in UMLS sematic-type assignment while building a
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semantic lexicon for clinical trial eligibility criteria. A total of 20 UMLS semantic types,
representing about 17% of all the distinct semantic types assigned to corpus lexemes,
covered about 80% of the vocabulary of our corpus.
Temporal knowledge representation from temporal express in clinical research
eligibility criteria is also a topic being actively investigated. Boland et al (2012) identified
the temporal knowledge representation requirements of eligibility criteria by reviewing
annotated 100 eligibility criteria. They developed EliXR-TIME, a frame-based
representation designed to support semantic annotation for temporal expressions in
eligibility criteria by reusing applicable classes from well-known clinical temporal
knowledge representations (Boland et al, 2012). Luo et al. (2011) presented an ontologybased approach for extracting temporal information from clinical trial eligibility criteria.
They developed a Conditional Random Field (CRF)-based parser, which is based on
Temporal Awareness and Reasoning Systems for Question Interpretation (TARSQI)
toolkit and the TimeText project, to automatically annotate the elements of temporal
constraints, specifically focusing on clinical trial eligibility criteria. The results were
evaluated with an additional 60 randomly selected eligibility criteria.
Another active research topic is effective and efficient search of clinical trials.
Korkontzelos et al (2012) presented Assisting Search and Creation Of clinical Trials
(ASCOT), a search application focused on clinical trials. Text mining and data mining
methods were applied to ASCOT and an eligibility criteria recommendation component
was included.
There has been much research on application, usage, and evaluation of UMLS.
Wu et al. (2012) examined characteristics of UMLS Metathesaurus terms in clinical
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notes. A 51 million document corpus of Mayo Clinic clinical notes was analyzed with
modified Aho-Corasick algorithm and the occurrences of UMLS terms were statistically
computed in terms of string attributes, source terminologies, semantic types, and
syntactic categories. They found that on average 44.64 term matched per document and
only 3.56% of the available case-insensitive terms in the UMLS were utilized. Aronson et
al. (2001) depicted a MetaMap program developed by the NLM to map biomedical text
to the UMLS Metathesaurus or to discover Metathesaurus concepts referred to in text.
Fung et al. (2010) investigated the problem list terminologies (PLT) of large healthcare
institutions and identified a subset of concepts based on standard terminologies. Data
were acquired from six large-scale healthcare institutions and mapped with the UMLS
Metathesaurus.
Feature selection and summarization of clinical trial is an emerging research
topic. Boland et al. (2013) investigated the feasibility of feature-based indexing,
clustering, and search of clinical trials. They argued that concept-oriented eligibility
features could enhance user search effectiveness, facilitating meaningful and efficient
indexing for clinical trials. In their study, concept-oriented eligibility features are a
clinically meaningful atomic patient state, such as diagnosis, symptom, or demographic
characteristics, which are derived from eligibility criteria. They argued that no studies
have ever examined feature-based indexing for clinical trials system; thus, their work
could set a baseline.
The ultimate goal of eligibility criteria analysis is directed at the automatic
matching process between a clinical trial and patients. Wilcox et al. (2009) presented a
model, electronic Participant Identification and Recruitment Model (ePaIRing), which
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uses patient information to enhance patient recruitment in clinical trials. The model was
created by grounded theory analysis, which is a qualitative approach. It iteratively collect
and interpret data to arrive at explanation of data (Wilcox et al., 2009).
Over the past decades a considerable number of studies have been done on
clinical trial and its subject eligibility criteria. However, no studies have ever tried to
generate a domain-specific lexicon resource, even though it is recognized that a domainspecific lexicon is fundamental of medical text analysis and foundation of NLP and text
mining. Thus, in the first essay, I generated a breast cancer-specific multi-gram lexicon
by inducing high impacted multi-gram terms from clinical trial description as well as
integrating heterogeneous online resources.

Table 1 show the selected research on clinical trial
Table 1. Selected Research on Clinical Trial
Authors

Journal

Title

Boland MR,
Miotto R, Gao J,
Weng C,

Methods of
Information in
Medicine (2013)

Feasibility of Feature-based
Indexing, Clustering, and
Search of Clinical Trials on
ClinicalTrials.gov: A Case
Study of Breast Cancer Trials,

Luo Z, Miotto R,
Weng C,

Journal of
Biomedical
Informatics
(2012)

A Human-Computer
Collaborative Approach to
Identifying Common Data
Elements in Clinical Trial
Eligibility Criteria

Weng C, Wu X,
Luo Z, Boland M,
Theodoratos D,
Johnson SB

Journal of the
American
Medical
Informatics
Association,
(2011)

EliXR: An Approach to
Eligibility Criteria Extraction
and Representation

Luo Z, YetisgenYildiz M, Weng C,

Journal of
Biomedical
Informatics,
(2011)

Dynamic Categorization of
Clinical Research Eligibility
Criteria by Hierarchical
Clustering

Topic / Research
Question

Theory/ Model

Data

To identify
Common Data
Elements (CDEs) in
eligibility criteria

association rulelearning algorithm ,
UMLS, dice
coefficient

Clinicaltrials.o
rg (breast
cancer and
cardiovascular
)

Finding /
Implication
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Authors

Journal

Title

Topic / Research
Question

Weng C, Tu SW,
Sim I, Richesson
R

Journal of
Biomedical
Informatics
(2010)

Formal Representations of
Eligibility Criteria: A
Literature Review

Review eligibility
criteria knowledge
representation

Thadani S, Weng
C, Bigger JT,
Ennever J,
Wajngurt D

Journal of the
American
Medical
Informatics
Association
(2009)

Electronic Screening
Improves Efficiency of
Clinical Trials Recruitment

evaluate the
performance of an
electronic screening
(E-screening)
method

Weng C,
McDonald DW,
Gennari JH,

International
Journal of
Medical
Informatics
(2007)

Participatory Design of a
Collaborative Clinical Trial
Protocol Writing System

Mary Regina
Boland, Samson
W. Tu, Simona
Carini, Ida Sim,
Chunhua Weng

Proc of 2012
AMIA Clinical
Research
Informatics
Summit

ELIXR-TIME: A Temporal
Knowledge Representation
for Clinical Research
Eligibility Criteria

temporal
expressions is
needed to facilitate
temporal
information
extraction

Theory/ Model

Analyze
publications

Data

Finding /
Implication

PubMed,
Google, 27
systems

significantly
reduced the
screening burden
associated with the
ACCORD trial

100 eligibility
criteria from
ClinicalTrials.
gov

EliXR-TIME, a
frame-based
representation
designed to support
semantic annotation
for temporal
expressions in
eligibility criteria
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125 patients,
investigator
review

Authors

Journal

Title

Luo Z, SB
Johnson, AM Lai,
Weng C

Proc of 2011
AMIA Fall
Symposium

Extracting Temporal
Constraints from Clinical
Research Eligibility Criteria
Using Conditional Random
Fields

Weng C, Batres C,
Borda T, Weiskopf
NG, Wilcox AB,
Bigger JT,
Davidson K,

Proc of 2011
AMIA Fall
Symposium

A Real-Time Screening Alert
Improves Clinical Trial
Recruitment Efficiency

Weng C, Bigger
JT, Busacca L, A
Wilcox, A
Getaneh,

Proc of AMIA
2010 Fall
Symposium

Comparing the Effectiveness
of a Clinical Data Warehouse
and a Clinical Registry for
Supporting Clinical Trial
Recruitment: A Case Study

Luo Z, Johnson
SB, Weng C,

Proc of AMIA
2010 Fall
Symposium

Semi-Automatic Induction of
Semantic Classes from FreeText Clinical Research
Eligibility Criteria Using
UMLS

Luo Z, Duffy R,
Johnson SB, Weng
C

Proc of AMIA
Clinical Research
Informatics
Summit 2010

Corpus-based approach to
create a semantic lexicon for
clinical research eligibility
criteria using UMLS

Topic / Research
Question

Theory/ Model

develop automated
approaches for
extracting the
primary constructs
of temporal
constraints in
clinical research
eligibility criteria

Conditional
Random Fields
(CRFs) to train a
temporal parser
from manuallyannotated criteria

Data

Finding /
Implication

150 temporal
eligibility
criteria
randomly
selected from
ClinicalTrails.
gov
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Authors

Journal

Title

Wilcox AB,
Natarajan K,
Weng C

Proc of AMIA
Translational
Bioinformatics
Summit 2009

Using Personal Health
Records for Automated
Clinical Trials Recruitment:
the ePaIRing Model

Li, L, Chase H,
Patel C, Friedman
C, and Weng C

Proc of 2008
AMIA Fall
Symposium

Comparing ICD9-Encoded
Diagnoses and NLPProcessed Discharge
Summaries for Clinical Trials
Pre-Screening: A Case Study.

Weng C, Becich
M, Fridsma D

The 2nd
International
Conference on
Information
Technology and
Communications
in Health, Feb
2007,

Collective Domain Modeling
across Clinical Trials
Standards: Needs,
Challenges, and Design
Implications

Weng C, Gennari
JH, McDonald
DW

11th World
Congress on
Medical
Informatics
(MedInfo’04)

A Collaborative Clinical Trial
Protocol Writing System

Topic / Research
Question

Theory/ Model

Data

Finding /
Implication
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Authors

Journal

Title

Gennari JH, Weng
C, McDonald
DW, Benedetti J,
Green S

11th World
Congress on
Medical
Informatics
(MedInfo’04)

An Ethnographic Study of
Collaborative Clinical Trial
Protocol Writing

Weng C,
McDonald DW,
Gennari JH

IT in Health Care:
Socio-technical
Approaches 2nd
International
Conference, 1314 September
2004

Participatory Design of A
Collaborative Clinical Trial
Protocol Writing System

Weng C, Kahn
MG, Gennari JH

Proc of AMIA
2002 Fall
Symposium

Temporal Knowledge
Representation for
Scheduling Tasks in Clinical
Trial Protocols.

Topic / Research
Question

Theory/ Model

Data

Finding /
Implication

19

Authors

Journal

Title

Topic / Research
Question

D.W. Lonsdale,
C. Tustison, C.G.
Parker, D.W.
Embley

Data & Knowledge
Engineering (2008)

Assessing clinical trial
eligibility with logic
expression queries

identification, extraction,
and query formulation of
information
regarding medical clinical
trials

Marc Cuggia,
Paolo Besana,
David Glasspool

International journal
of medical
informatics (2011)

Comparing semi-automatic
systems for recruitment of
patients to clinical trials

review decision support
systems for automatic
recruitment of patients to
clinical trials

Ida Sim, Ben
Olasov, and
Simona Carini

Journal of
Biomedical
Informatics (2004)

An ontology of
randomized controlled
trials for evidence-based
practice: content
specification and
evaluation using the
competency decomposition
method

Y. Megan Kong,
Carl Dahlke, Qun
Xiang, Yu Qian,
David Karp,
Richard H.
Scheuermann

Journal of
Biomedical
Informatics(2011)

Toward an ontology-based
framework for clinical
research databases

developing RCT Bank to
capture detailed
information
about the design,
execution, and results of
RCTs

integrate data
standards and ontology
structures of knowledge
representation

Theory/ Model

Data

Finding / Implication

web-based
information
extraction

Query generation

competency
decomposition

RCT Schema using
UMLS

database
implementation of
the OBX model

Ontology-Based
eXtensible (OBX) data
model
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Authors

Journal

Title

Topic / Research
Question
relationship between
terminological
annotations and the
UMLS Semantic
Network (SN) that can be
exploited to improve
those annotations

Guoqian Jiang,
Harold R.
Solbrig,
Christopher G.
Chute

Journal of
Biomedical
Informatics(2011)

Quality evaluation of
cancer study Common
Data Elements using the
UMLS Semantic Network

P.J. Embi et al.

Arch Intern Med,
(2005)

Effect of a clinical trial
alert system on physician
participation in trial
recruitment

Acad Med (2012)

ResearchMatch: a national
registry to recruit
volunteers for clinical
research

P.A. Harris et al.

S.W. Tu et al.

Journal of
Biomedical
Informatics (2011)

A practical method for
transforming free-text
eligibility criteria into
computable criteria

creating computerinterpretable languages
for eligibility criteria

Theory/ Model

Data

Finding / Implication

UMLS SN

caDSR CDE
Browser

the UMLS SN based
profiling approach is
feasible
for the quality
assurance and
accessibility of the
cancer study
CDEs

ERGO
annotations

1000
eligibility
criteria
randomly
drawn from
ClinicalTrials
.gov

incrementally
capturing the
semantics of free-text
eligibility criteria
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Authors

J. Nahar et al.
Peter J. Embi,
MD, MS; Anil
Jain, MD; Jeffrey
Clark, BS; Susan
Bizjack, MSN;
Richard
Hornung, DrPH;
C. Martin Harris,
MD, MBA
Stephanie
Heinemann,
Sabine Thüring,
Sven Wedeken,
Tobias Schäfer,
Christa ScheidtNave, Mirko
Ketterer,
Wolfgang
Himmel1

Journal

Title

Topic / Research
Question

Theory/ Model

Data

Finding / Implication

The CTA intervention
was associated with
significant increases in
the number of
physicians

J Med Syst,

Significant cancer
prevention factor
extraction: an association
rule discovery approach

Arch Intern Med.
(2005)

Effect of a Clinical Trial
Alert System on Physician
Participation in Trial
Recruitment

the resources of a
comprehensive EHR can
be leveraged for the
benefit of clinical trial
recruitment

EHR-based
clinical trial alert
(CTA) system

From
Cleveland
Clinic

BMC Medical
Research
Methodology 2011,

A clinical trial alert tool to
recruit large patient
samples and assess
selection bias in general
practice research

evaluate the recruitment
performance of the
practice staff when using
the CTA tool according to
4 criteria

clinical trial alert
(CTA) tool

GP’s data
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2.3. Background
Tokenization
Tokenization is the process of breaking up a stream of text into words,
phrases, symbols, or other meaningful elements called tokens. The list of tokens
becomes input for further processing, such as parsing or text mining (Manning et al.,
2008). Manning et al. (2008) defined a token as “an instance of a sequence of
characters in some particular document that are grouped together as a useful semantic
unit for processing.” Table 2 explains an example of tokenization.

Table 2. Example of Tokenization (Manning et al., 2008)

Input

Friends, Romans, Countrymen, lend me your ears

Output

Friends Romans Countrymen lend me your ears

Lemmatization
For grammatical reasons, there are diverse forms of a word, such as organize,
organizes, and organizing. Likewise, families of derivationally related words with
similar meanings, such as democracy, democratic, and democratization, are common
in textual data. In NLP and text mining, it is useful for a search of words to return
documents that contain another word in the set. The goal of lemmatization is to
reduce inflectional forms and derivationally related forms of a word to a common
base form.
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There are two different approaches to obtain a common base form: stemming
and lemmatization. Stemming refers to a crude process that cuts off the end of words
in order to acquire a base form and includes the removal of derivational affixes.
Lemmatization refers to a process that uses a vocabulary and morphological analysis
of words for the purpose of removing inflectional endings and returning the base or
dictionary form of a word called lemma. Lemmatization makes use of full
morphological analysis to accurately identify the lemma for each word. In this study,
I use lemmatization rather than stemming, which does not guarantee returning
grammatically correct words.
Table 3 shows an example of lemmatization, and Table 4 shows an example
of lemmatization with a sentence.

Table 3. Example of Lemmatization (Manning et al., 2008)

Base Form

Inflectional or Derivationally related form

be

am, are, is

car

car, cars, car’s cars’

Table 4. Example of Lemmatization with a Sentence (Manning et al., 2008)

Original Sentence

the boy's cars are different colors

Lemmatization

the boy car be differ color
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Stop Word Removal
A document is a combination of sentences, and a sentence is a set of words. A
word is a complicated combination of characters. There is a variety of words and
special characters that do not have significant meaning. Some extremely common
words called stop words would appear to be of little value in NLP and text mining
process. Examples of stop words are “the,” “of,” “to,” and “a. ” These are required
to satisfy English grammar rules even though they have no semantic meaning.
Moreover, special characters such as the period and question mark used to indicate
the end of a sentence or an interrogative sentence, respectively, are considered to be
noise in NLP. Therefore, all of the stop words need to be removed in the preprocessing step.
The general strategy for removing stop words in English is to use a stop list
that is a negative dictionary. Fox (1989) reported a stop list based on the Brown
corpus of 1,014,000 words drawn from a broad range of literature in English. The
final product of Fox’s work is a list of 421 stop words that would be maximally
efficient and effective in filtering the most frequently occurring and semantically
neutral words.
This study adopts Fox’s stop list to cull all insignificant words in data.

Representation of Textual Documents and Vector Space Model

Text representation is one of the pre-processing processes that is used to
reduce the complexity of documents and make them easier to handle. To implement
any technique of text mining, it is initially necessary to transform the digitized texts
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in an efficient and meaningful way so that they can be analyzed.
The space vector model is the most commonly used approach to represent
textual documents. This approach represents a text by a numerical vector obtained by
counting the most relevant lexical elements present in the text (Amine et al., 2008).
All documents d will be transformed into a vector:

dj = (w1j ,w2j , ...,w|T|j)

(1)

Where T is the whole set of terms (or descriptors) that appear at least once in

the corpus (|T| is the size of the vocabulary), and  represents the weight
(frequency or importance) of the term tk in the document 

Table 5 represents a Document Term Matrix model.
Table 5. Document Term Matrix

Documents

Terms or Descriptors

d1

w11

w21

w31

…

wj1

…

wn1

d1

w12

w22

w32

…

wj2

…

wn2

…

…

…

…

…

…

…

…

dm

w1m

w2m

w3m

…

wjm

…

wnm

I represented each clinical trial document by a vector in a multidimensional
space. Each word constitutes a dimension in this space. When a word is absent in a
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clinical trial document, its value along the corresponding dimension is 0. When a
word occurs in the document, the value along the dimension is determined by a
weight factor indicating its importance.
The simplest representation of texts introduced within the framework of the
vector space model is called Bag of Words (BOW) (Salton and McGil, 1986). It
consists of texts transformed into vectors where each component represents a word.
This representation of texts excludes any grammatical analysis and any concept of
distance between the words, and syntactically destructures texts by making them
understandable to the machine.

Term Frequency - Inverse Document Frequency (TF-IDF)
TF-IDF is a numerical statistic that is intended to reflect how important a
word is to a document in a collection or corpus. There are many methods to calculate
the weight wkj knowing that for each term, it is possible to calculate not only its
frequency in the corpus but also the number of documents that contain this term.
Most approaches (Sebastiani, 2002) are centered on a vectorial representation
of texts using the TF-IDF measure. The frequency TF of a term T in a corpus of
textual documents corresponds to the number of occurrences of the term T in the
corpus. The frequency IDF of a term T in a corpus of textual documents corresponds
to the number of documents containing T. These two concepts are combined (by
product) in order to assign a stronger weight to terms that appear often in a document
and rarely in the complete corpus.
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TF×IDF ,  =Occ ,  ×

_

_( )

Where Occ ,  is the number of occurrences of the term  in the

document  , Nb_doc is the total number of documents of the corpus and Nb_doc( )
is the number of documents of this unit in which the term  appears at least once
(Amine et al., 2008).

N-gram and N-gram Induction
N-gram (Damashek, 1995) is a character sequence of length n extracted from
a document. To generate the n-gram vector for a document, a window n characters in
length is moved through the text, sliding forward by a fixed number of characters
(usually one) at a time. At each position of the window, the sequence of characters in
the window is recorded. For example, the first three 5-grams in the phrase “character
string” are “chara,” “harac,” and “aract.” Damashek (Damashek, 1995) suggested the
use of character n-grams instead of words for gauging text similarity. N-gram
retrieval promises lower vulnerability to data entry errors, spelling varieties, word
conjugations, and other morphological varieties.
The concept of n-grams was first discussed in 1951 by Shannon (Shannon,
1951). Since then, n-grams have been used in many areas, such as spelling-related
applications, string searching, prediction and speech recognition.

Word n-gram is a

sequence of consecutive tokens, with the length of n. Mostly words are taken as
tokens, but in recent works, characters could also be token (Trenkle and Cavnar,
1994).
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A word n-gram feature induction, sometimes also referred to as feature
extraction, induces features on textual data based on a set of word n-grams. With
feature induction, the textual data is represented in a feature space, usually encoding
the existence of these word n-grams or their frequency. The word n-grams to be used
as features may be chosen by either using a data driven approach or dictionary-based
approach.
In a data driven feature induction, every word n-gram combination from the
textual data is created. Thus, the feature size equals the word n-gram vocabulary size.
Such a data driven feature induction does not require prior domain knowledge to
recognize meaningful word n-grams.
In a dictionary approach, n-gram tokens are selected based on a custom
lexicon database that focuses on a specific domain. In this approach, it is proposed
that an n-gram feature selection that maps all bigram and trigram tokens to the custom
lexicon database be used.

Named Entity Recognition (NER)
Named Entity Recognition (NER) is the task of identifying and classifying
entities such as person names, place names, organization names, etc., in a given
document. Named entities play a major role in information extraction. A wellperforming NER is important for further levels of NLP techniques. Many techniques
have been applied in English for NER. Some of them are rule-based systems (Krupka
and Hausman, 1998), which make use of dictionary and patterns of named entities.
Examples are Decision trees (Karkaletsis et al., 2000), Hidden Morkov Model
(HMM) (Biker, 1997), Maximum Entropy Morkov Model (MEMM) (Borthwick et
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al., 1998), and Conditional Random Fields (CRF) (Andrew McCallum and Wei Li,
2003). The approaches can be classified as a rule-based approach, machine learning
approach, or hybrid approach.
NER has been done generically but can also be domain-specific where a finer
tagset is needed to describe the named entities in a domain. Domain-specific NER is
common and has been in existence for a long time in the bio-domain (Settles 2004)
for identification of protein names, gene names, DNA names, etc. The NER task is
also viewed as the first step of information extraction of free text clinical studies
describing shock, trauma, inflammation, and other related states (Apostolova et al.,
2008). The proposed custom dictionary also supports the NER process in the
healthcare domain.
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2.4. Research Method

Figure 3. Steps for Building Domain Specific Dictionary

Figure 3 represents the steps for building breast cancer domain-specific
dictionary in essay 1.
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2.4.1 Data Set
I collected 378 clinical trials using search term ‘Breast Cancer’ that was listed
in ClinicalTrials.gov between January 1, 2010 and January 1, 2011, and downloaded
all the related information as a collection of individual XML files.
All XML tags and metadata were removed and only the <eligibility> <criteria> - <textblock> section was extracted. Since subject eligibility criteria text is
in free text format and contains two opposite criteria, “inclusion” and “exclusion”, I
separated subject eligibility criteria text blocks based on the key words “Inclusion
criteria” and “Exclusion criteria.”

2.4.2 Building Dictionary
I constructed a domain-specific n-gram term dictionary for the breast cancer
domain. The custom dictionary was based on high TF-IDF score words from the
clinical trial eligibility data set and other online resources (i.e., NCI Dictionary of
Cancer Terms, Breastcancer.org, and ACS Breast Cancer Dictionary). The n-gram
term dictionary for breast cancer domain can be a resource for dictionary-based feature
induction that uses a pre-defined dictionary as well as an NER process.

First, during pre-processing, tokenization, lemmatization, and stop word
removal were performed over the selected data set.
Second, I calculated the TF-IDF score for all unigram features that drew from
the breast cancer clinical trial eligibility text data set. Three experts reviewed all
26,193 unigram list organized in descending order by TF-ID score, and they manually
identified bigram and trigram terms from the unigram list. The review was conducted
sequentially. The output of first reviewer was forwarded to second reviewer and the
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results from second reviewer was validated by the third reviewer. The review process
was iterated among three reviewers until all reviewer agreed on identified bigram and
trigram. The final review was conducted by expert who is medical doctor as well as
Ph.D. Only adjacent words were considered. After expert review, a total of 1,506
multi-gram terms were identified.
Third, an online medical term crawler was developed by the author in Ruby
language to gather breast cancer terms from web sites. The crawler automatically
collected web documents from the targeted site and parsed the documents to extract
medical terms. All unnecessary tags were removed. The crawler collected 4,704 terms
from the NCI dictionary of Cancer Terms, 910 terms from Breastcancer.org, 155
terms from the ACS Breast Cancer Dictionary, and 28 terms from breast cancer
glossary of Terms in emedicinehealth.com. All the collected items were stored in
MySql database and duplicates were removed by SQL query. Table 6 shows the
number of dictionary items by the source.

Table 6. Number of Item by Source

Source

Number of item

NCI Dictionary of Cancer Terms

4,704

Clinical Trial cluster

1,506

Breastcancer.org

910

ACS Breast Cancer Dictionary

155

emedicinehealth.com

28

Total

7,303
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The custom dictionary included total 7,303 items. The dictionary included 707
trigram, 2,098 bigram, 4,162 unigram, and 336 n-grams terms consisting of more than
three words that were identified. Table 7 shows the number of dictionary items by the
type of n-gram.

Table 7. Number of Item by N-Gram Type

Type of n-gram

Number of item

1

4,162

2

2,098

3

707

4

191

5

93

6

37

7

11

8

3

9

1

Total

7,303
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2.5. Evaluation
Two experiments were conducted to evaluate the efficiency of the domainspecific dictionary. First, all items in the custom dictionary were directly matched
with the SNOMED CT in UMLS Metathesaurus to examine uniqueness of the custom
dictionary items. Only English terms in SNOMED CT were used for evaluation. I
created a database query with Structured Query Language (SQL) and ran the query to
evaluate uniqueness. The SQL query selected all items in the custom dictionary and
matched each item with terms in SNOMED CT. According to the query result, 4,243
items in the custom dictionary were unique and 3,060 items overlapped with
SNOMED CT. This evaluation showed that around 58% of the custom dictionary
items are newly introduced as a lexicon resource. This is significantly high and
should not be overlooked. Table 8 shows number of unique item for different types of
n-gram in the custom dictionary.
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Table 8. Number of Unique Items in the Custom Dictionary

Type of n-gram

Number of Unique Item

1

2168

2

1299

3

486

4

159

5

84

6

32

7

11

8

3

9

1

Total

4,243

Second, the items in the custom dictionary and in SNOMED CT were
matched with test data set to validate usefulness of custom dictionary for processing
clinical trial data. A total 1,058 clinical trial studies from January 1, 2011, to January
1, 2013 were collected from the CliniclTrial.gov and the subject eligibility criteria
section was divided into two parts, inclusion criteria and exclusion criteria. These two
data sets were pre-processed with tokenization, lemmatization, and stop word
removal. All possible trigram and bigram combination were generated to match with
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the proposed custom dictionary and SNOMED CT. The matching results for trigram
and bigram are presented in Table 99 and Error! Reference source not found.

Table 9. Trigram Matching

Trigram Matching
Number of
Matched Items
Using the
Custom
Dictionary
Only

Number of
Matched Items
Using
SNOMED CT
Only

Number of
Matched Items
Using the Custom
Dictionary and
SNOMED CT

Additional
Number of
Unique Items
Matched by
Custom
Dictionary

Inclusion Data

828

904

1,439

535

Exclusion
Data

748

984

1,226

242

Total

1,576

1,888

2,665

777

Table 10. Bigram Matching

Bigram Matching
Number of
Matched Items
Using the
Custom
Dictionary
Only

Number of
Matched Items
Using
SNOMED CT
Only

Number of
Matched Items
Using the Custom
Dictionary and
SNOMED CT

Additional
Number of
Unique Items
Matched by
Custom
Dictionary

Inclusion Data

4,842

6,932

9,610

2,678

Exclusion
Data

4,158

5,958

8,198

2,240

Total

9,000

12,890

17,808

4,918

According to the matching results, the SNOMED CT matched most items
which were expected since the size of SNOMED CT is much larger than the custom
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dictionary in both trigram and bigram. However, the number of matched items by
using both the custom dictionary and SNOMED CT is greater than the number of
matched items using SNOMED CT only. As shown in Table 9, 777 additional trigram
matches were done by adding custom dictionary to SNOMED CT only match. This
represents a 41% increase over SNOMED CT only match. Similarly as shown in
Table 10, 4,918 additional bigram matches were done by adding custom dictionary to
SNOMED CT only match. This represents a 38.6% increase over SNOMED CT only
match. Thus, custom dictionary significantly increases the size of matches.

2.6. Discussion
One of the most time consuming and high labor cost tasks in text mining
research is the creation, compilation, and customization of the necessary lexicons
(Jonnalagadda et al., 2013). Lexical resources are requisite to improve the
performance of text mining, especially in NER. For the healthcare informatics
researchers, it is required to implement modularized systems that cannot be
generalized, therefore the building of customized lexical resources is needed for these
highly specific systems (Stanfill et al., 2010).
This research has attempted to build a domain-specific lexicon focusing on
breast cancer and has shown the semi-automated dictionary building process. The
evaluations for breast cancer domain-specific dictionary using the clinical trial subject
eligibility documents revealed that even though the total number of matched items
using the custom dictionary is than the number of matched items using SNOMED
CT, about 30% of matched items using the custom dictionary and SNOMED CT were
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derived from the custom dictionary. This shows the importance of the domain
specific dictionary and expert knowledge in lexicon resources.
There is no research that is free from limitation. First, coverage rate of
domain-specific dictionary is relatively low. The domain-specific dictionary included
limited online sources. Thus, if more extensive resource such as NCI Thesaurus is
included in future research, it will result in better performance. The evaluation of this
research only calculated the matched terms with test data set. If an annotated data as
gold standard is available, more sophisticated evaluation metrics such as precision,
recall, and F-measure could be included. In future research, with expert’s annotation
for test data set, the most popular performance measures in information retrieval,
accuracy, precision, recall, and F-measure could be evaluated.

40

CHAPTER 3
Essay 2: Clustering Clinical Trials Using
Semantic-Based Feature Expansion

“The problems are solved, not by giving new information,
but by arranging what we have known since long.”

Ludwig Wittgenstein

3.1. Introduction
The subject eligibility criteria section is one of the essential parts of clinical
research protocols since it specifies the inclusion and exclusion characteristics of
clinical research participants. Since clinical trial protocols and result data have been
digitized and made publicly available by the National Institutes of Health (NIH),
there has been an increasing need for developing novel approaches that exploit such
an invaluable resource. However, there are several challenges to acquiring
meaningful knowledge from an unstructured data source (Bollier, 2010).
One of the salient issues in data analysis is information overload. When
searching relevant clinical trials in the one of largest online clinical trial repositories,
ClinicalTrials.gov, which includes more than 190,000 clinical trial studies, the same
information overload problem was encountered. Many scholarly methods such as
EmergingMed, SearchClinicalTrials.org, and TrialX application have been developed
to address this problem. Although a large number of studies have been made on
narrowing the clinical trial search scope, they required users to create complex
queries (Hao, 2014).
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An alternative option for a query-based clinical trial search is a case-based
search by clustering trials, which can identify and suggest similar trial to an example
trial (Hao, 2014). This approach can alleviate user burden to create complex query
and can be useful for multiple usage cases. Clinical trial participants, clinical trial
investigators, and meta-analysis researchers can benefit from the case-based search
approach (Hao, 2014). To support case-based clinical trial search, it is necessary to
develop an automated method for identifying and grouping semantic classes that
belong to clinical trial subject eligibility criteria.
Interpretation of a subject eligibility section by means of a computer has
received considerable attention for its promising applications in clinical trial research,
especially in automatically matching patients to clinical trial studies (Luo, 2010).
Inducing sematic classes from text data is an efficient way to understand text data and
it is required to induce semantic classes from clinical trial eligibility criteria to
understand that. Clustering is a popular solution for inducing semantic classes for
various applications, such as ontology development, content organization, and
thesaurus construction (Cheng et al., 2004; Pratt and Fagan, 2000; Lin, 1998).
In this research, we present a novel approach for reducing clinical trial
information search space, which uses the result of hierarchical clustering with the ngram model and semantic-based feature expansion technique.

3.2. Background Literature
Table 11 presents the selected research on clinical trial using NLP and text mining.
Table 11. Selected Research on Clinical Trial using NLP and Text Mining
Authors

Tianyong Hao et
al.

S.W. Tu et al.

Guoqian Jiang,
Harold R. Solbrig,
Christopher G.
Chute

Journal

Journal of
Biomedical
Informatics
(2014)

Journal of
Biomedical
Informatics,
(2011)

Journal of
Biomedical
Informatics
(2011)

Title

Clustering clinical trials
with similar eligibility
criteria features

Topic / Research
Question
Identify and cluster
clinical trials with
similar eligibility
features.

A practical method for
transforming free-text
eligibility criteria into
computable criteria

Creating computerinterpretable
languages for
eligibility criteria

Quality evaluation of cancer
study Common Data Elements
using the UMLS Semantic
Network

Relationship
between
terminological
annotations and the
UMLS Semantic
Network (SN) that
can be exploited to
improve those
annotations

Data

Finding /
Implication

Center-based
clusters

From
ClinicalTrials.
gov

useful for clinical
trial eligibility
criteria designs and
for improving
clinical trial
recruitment

ERGO annotations

1000
eligibility
criteria
randomly
drawn from
ClinicalTrials.
gov

incrementally
capturing the
semantics of freetext eligibility
criteria

caDSR CDE
Browser

the UMLS SN
based profiling
approach is feasible
for the quality
assurance and
accessibility of the
cancer study
CDEs

Theory/ Model

UMLS SN
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Authors

Journal

Title

Boland MR,
Miotto R, Gao J,
Weng C,

Methods of
Information in
Medicine(2013)

Feasibility of Feature-based
Indexing, Clustering, and
Search of Clinical Trials on
ClinicalTrials.gov: A Case
Study of Breast Cancer Trials

Luo Z, YetisgenYildiz M, Weng C,

Journal of
Biomedical
Informatics
(2011)

Dynamic Categorization of
Clinical Research Eligibility
Criteria by Hierarchical
Clustering

Luo Z, Johnson
SB, Weng C,

Proc of AMIA
2010 Fall
Symposium

Semi-Automatic Induction of
Semantic Classes from FreeText Clinical Research
Eligibility Criteria Using
UMLS

Weng C, Wu X,
Luo Z, Boland M,
Theodoratos D,
Johnson SB

Journal of the
American
Medical
Informatics
Association,
(2011)

EliXR: An Approach to
Eligibility Criteria Extraction
and Representation

Topic / Research
Question

Theory/ Model

Data

Finding /
Implication
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3.3. Background
Unified Medical Language System (UMLS)
UMLS was initiated in 1989 by the National Library of Medicine (NLM), which
continues to maintain it. It is an attempt to fill the gap among the medical vocabularies
from heterogeneous sources. The purpose of UMLS is to facilitate the development of
computer systems that deal with the semantics of the language of biomedicine and health.
NLM provides system developers with the UMLS Knowledge Sources (database) and
related software applications (programs) for building healthcare information systems that
create, process, retrieve, integrate, and aggregate biomedical and health data, as well as
for use in academic research (Kohler 2008;
http://www.nlm.nih.gov/pubs/factsheets/umls.html).
UMLS consists of three knowledge sources, which are the Metathesaurus, the
Semantic Network, and the SPECIALIST Lexicon. Moreover, the three knowledge
sources comprise several tools that facilitate the use of UMLS.

Metathesaurus
The Metathesaurus is a very large, multipurpose, and multilingual vocabulary
database that is organized by concepts. The current release contains more than 1.5 million
biomedical terms from over 150 different sources. Synonymous terms are clustered
together to form a concept. For example, "breast cancer," "breast tumor malignant," and
"malignant neoplasm of breast" belong to the same UMLS concept. The concept unique
identifier (CUI) for "breast cancer" is C0006142.
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There are various types of relationships that link concepts to other concepts. Interconcept relationships are not only inherited from the vocabulary sources but are also
created by the Metathesaurus editors. All concepts in the Metathesaurus are assigned to at
least one semantic type from the Semantic Network to keep consistent categorization at
the general level depicted in the Semantic Network.

Semantic Network
The main purpose of the Semantic Network is to provide a consistent
categorization of all concepts stored in the Metathesaurus and information about a set of
basic semantic types or categories. The Network contains 133 semantic types and 54
relationships. There are major groupings of semantic types under topics such as
organisms, anatomical structures, biologic function, chemicals, events, physical objects,
and concepts or ideas. The scope of the UMLS semantic types is quite wide; therefore, it
permits the semantic categorization to include a wide range of terminologies over
multiple domains.
The Semantic Network is organized using a directed graph, where the semantic
types represent the nodes and the relationships among them are the edges. Figure 4
illustrates a portion of the Network. The semantic type "Biologic Function" has two
children, "Physiologic Function" and "Pathologic Function," and each of these in turn has
several children. Each child and parent in the hierarchy is linked by an "is-a" link. Figure
5 illustrates a portion of the hierarchy for Network relationships. The "affects"
relationship has six children, including "manages", "treats," and "prevents." Figure 6
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shows a portion of the Semantic Network illustrating the relations, either hierarchical or
associative, that exist between semantic types.

Figure 4. A Portion of the UMLS Semantic Network: “Biologic Function” Hierarchy
(UMLS Reference Manual, 2009)

Figure 5. A Portion of the UMLS Semantic Network: “Affects” Hierarchy
(UMLS Reference Manual, 2009)
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Figure 6. A Portion of the UMLS Semantic Network: Relations
(UMLS Reference Manual, 2009)

SPECIALIST Lexicon and Lexical Tools
The SPECIALIST Lexicon is a general English lexicon including many
biomedical vocabularies, and the Lexical Tools are designed to resolve the high degree of
variability in natural language. The syntactic, morphological, and orthographic
information for each term in the Lexicon is recorded by the SPECIALIST NLP system.
The inflected forms of words or terms are appropriately considered instances of the same
word.
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3.4. Research Method
Figure 7 shows the steps of clinical trial clustering process using UMLS. First, I
collected clinical trial information for breast cancer from ClinicalTrial.gov and parsed
original XML format files. Next, only eligibility criteria section from clinical trial was
extracted and pre-processed using tokenization, lemmatization, and stop word removal.
Breast cancer specific dictionary and UMLS Metathesaurus were used for finding n-gram
terms and semantic feature expansion. Agglomerative hierarchical clustering algorithms
were applied to create clusters for the inclusion and exclusion data set and then
intersectional clusters were derived. Finally, a label for intersectional cluster was created.
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Figure 7. Steps for Clinical Trial Clustering Using Domain-Specific Dictionary and UMLS

50

3.4.1. Data Set
I collected the clinical trials from ClinicalTrials.gov, which is a registry and
results database of publicly and privately supported clinical studies of human participants
conducted around the world. I used the search term "breast cancer" to limit clinical trials
to only the breast cancer domain and then collected three years of data from January 1,
2010, to January 1, 2013. The total number of clinical trials collected is 1,660, all
information on the trials were downloaded as a collection of individual Extensible
Markup Language (XML) format files. XML is a markup language that defines a set of
rules for encoding a document in a format that is both human-readable and machinereadable. The World Wide Web Consortium (W3C) produces the specifications for XML
1.0 and XML and has come into common use for the interchange of data over the Internet
(http://en.wikipedia.org/wiki/XML).
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Figure 8 shows a sample of an original clinical trial XML document.

Figure 8. Sample of Original Clinical Trial XML Document (NCT01483196.xml)

To parse an XML document and remove unnecessary tags, I developed a custom
parser using the Ruby programming language. All XML tags metadata were removed and
only the <eligibility> - <criteria> - <textblock> section was extracted. Subject eligibility
criteria text was in a free text format and could be divided by two opposite criteria:
“Inclusion” and “Exclusion.” I separated the subject eligibility criteria text block based
on the key word “Inclusion criteria” and “Exclusion criteria.” There were several upper
and lower case variations in the keyword such as “INCLUSION CRITERIA,” “inclusion
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criteria,” and “inclusion Criteria.” The regular expression was used to capture all letter
case variations. Once the eligibility criteria text was divided into two sections, all key
words representing inclusion and exclusion were removed by the pre-processing step.
Table 12 presents a sample of a criteria section extracted from the clinical trial id
NCT0506700. The inclusion criteria set and exclusion criteria set were managed
separately. The gender and age range were basic structured eligibility criteria that gave
significant information during the matching process between the clinical trial and patient
information. Thus, I extracted those two sections and included them with the data file
naming rule. The naming rule for each eligibility criteria was <clinical trial ID_gender
criteria_minimum age_maximu age>; as a result, the data file name for NCT050670 was
modified to “NCT0506700_Female_18_NA.” This file name implied that females over
age 18 were eligible to participate in the clinical trial NCT0506700.

Table 12. Sample of Extracted Eligibility Criteria Text (ID; NCT0506700)

Inclusion Criteria:
2. Signed ICF

1. Women 18 years of age or older
3. Women who have been histologically

diagnosed with invasive ductal carcinoma or

invasive

lobular carcinoma of the breast prior to surgery
Planning breast preservation

5. Patients undergoing

lumpectomy (partial mastectomy) procedure
Original criteria

Criteria:

Exclusion

1. Multicentric disease (histologically diagnosed

cancer in two different quadrants of
Neoadjuvant systemic therapy

the breast)

2.

3. All T4 tumors

4.

Previous radiation in the operated breast
procedure in the same quadrant
operated breast

4.

7. Pregnancy

5. Prior surgical

6. Implants in the
8. Lactation
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9. Participating in any other investigational study for either drug
or device which can

influence collection of valid data

under this study
1. Women 18 years of age or older

2. Signed ICF

3. Women who have been histologically diagnosed with
invasive ductal carcinoma or
Inclusion only

invasive lobular

carcinoma of the breast prior to surgery
breast preservation

4. Planning

5. Patients undergoing lumpectomy

(partial mastectomy) procedure
1. Multicentric disease (histologically diagnosed cancer
in two different quadrants of

the breast)

Neoadjuvant systemic therapy

3. All T4 tumors

Previous radiation in the operated breast
Exclusion only

procedure in the same quadrant
operated breast

7. Pregnancy

2.
4.

5. Prior surgical

6. Implants in the
8. Lactation

9. Participating in any other investigational study for either drug
or device which can

influence collection of valid data

under this study

3.4.2. Pre-processing
For the first pre-processing step, I performed tokenization and lemmatization for
the inclusion and exclusion data sets with Stanford CoreNLP, which is an integrated
framework that provides a set of natural language analysis tools, including the part-ofspeech (POS) tagger, the named entity recognizer (NER), the parser, the co-reference
resolution system, the sentiment analysis tools, and model files for analysis of English
(http://nlp.stanford.edu/software/corenlp.shtml). The Stanford CoreNLP code is written
in Java and licensed under the GNU General Public License (v2 or later) and requires
Java 1.6 or higher version.
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The second pre-processing step was stop word removal. The Apache Lucene
framework, a high-performance and full-featured text search engine library written
entirely in Java, was used to remove stop words (http://lucene.apache.org/core/). Apache
Lucene is an open source project available for free download. This study adopted Fox’s
stop word list to cull all insignificant words in the data.
Table 13 presents a sample of the preprocessed inclusion and exclusion criteria
text NCT01506700.
Table 13. Sample of Preprocessed Inclusion and Exclusion Criteria

woman 18 year age older sign icf woman histologically
Pre-processed
Inclusion Criteria

diagnose invasive ductal carcinoma invasive lobular carcinoma
breast prior surgery Planning breast preservation patient
undergo lumpectomy partial mastectomy procedure
multicentric disease histologically diagnose cancer two different
quadrant breast neoadjuvant systemic therapy t4 tumor previous

Pre-processed
Exclusion Criteria

radiation operate breast prior surgical procedure same quadrant
implant operate breast pregnancy Lactation participate
investigational study drug device influence collection valid
datum under study

3.4.3. Matching with Custom Dictionary
The domain-specific dictionary for breast cancer described in essay 1 was utilized
to detect n-gram terms in the inclusion or exclusion criteria data set. In this first step, I
identified all trigram combinations from the preprocessed data set and then matched each
trigram term with the custom dictionary that has n-gram terms for the breast cancer
domain. Once the trigram term was matched with the term in the custom dictionary, three
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unigram tokens that consisted of the trigram were removed from the data. I replaced the
space in the trigram with an underscore (_) to transform the trigram into the single token
form because all identified trigram and bigram words should be considered as unigram
terms to maintain the original n-gram form. After the trigram matching step was
completed, all bigram combinations from the modified data set were drawn and matched
with the custom dictionary. Table 14 shows all trigram combinations from NCT0506700
and the results of the custom dictionary matching. From the pre-processed inclusion
criteria presented in Table 14, I generated all trigram combinations that listed in Table 15.
The first three tokens for clinical trial id ‘NCT01506700’ are ‘woman’, ‘18’, ‘year’, so
trigram ‘woman 18 year’ was generated and this trigram compared with the custom
dictionary. If the trigram ‘woman 18 year’ was found in the custom dictionary, the three
unigram tokens, ‘woman’, ‘18’, and ‘year’ were removed from original data set and
replaced with ‘woman_18_year’. Otherwise, the first three token was kept and the
combination window for trigram slid to next token and generated second possible trigram
combination ’18 year age’. All possible trigram combination from clinical trial id
‘NCT01506700’ inclusion criteria were compared with the custom dictionary and found
two trigram matches ‘invasive ductal carcinoma’ and ‘invasive lobular carcinoma’.

Table 14. All Trigram Combinations from NCT01506700 and
Results of the Custom Dictionary Matching

Inclusion /
Exclusion

All Trigram Combinations
woman 18 year

Inclusion
Criteria

18 year age
year age older

Matching with
The Custom Dictionary
invasive ductal carcinoma
invasive lobular carcinoma
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age older sign
older sign icf
sign icf woman
icf woman histologically
woman histologically diagnose
histologically diagnose invasive
diagnose invasive ductal
invasive ductal carcinoma
ductal carcinoma invasive
carcinoma invasive lobular
invasive lobular carcinoma
lobular carcinoma breast
carcinoma breast prior
breast prior surgery
prior surgery Planning
surgery Planning breast
Planning breast preservation
breast preservation patient
preservation patient undergo
patient undergo lumpectomy
undergo lumpectomy partial
lumpectomy partial mastectomy
partial mastectomy procedure
multicentric disease histologically
disease histologically diagnose
histologically diagnose cancer
Exclusion
Criteria

diagnose cancer two
cancer two different
two different quadrant
different quadrant breast
quadrant breast neoadjuvant

No Match
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breast neoadjuvant systemic
neoadjuvant systemic therapy
systemic therapy t4
therapy t4 tumor
t4 tumor previous
tumor previous radiation
previous radiation operate
radiation operate breast
operate breast prior
breast prior surgical
prior surgical procedure
surgical procedure same
procedure same quadrant
same quadrant implant
quadrant implant operate
implant operate breast
operate breast pregnancy
breast pregnancy Lactation
pregnancy Lactation participate
Lactation participate investigational
participate investigational study
investigational study drug
study drug device
drug device influence
device influence collection
influence collection valid
collection valid datum
valid datum under
datum under study
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Table 15 shows all possible bigram combinations from NCT0506700 and the
results of the custom dictionary matching. I generated all bigram combinations that listed
in Table 15 from the pre-processed inclusion criteria presented in Table 14. The first two
tokens for clinical trial id ‘NCT01506700’ are ‘woman’ and ‘18’, so bigram ‘woman 18’
was generated and then compared with the custom dictionary. If the bigram ‘woman 18’
was found in the custom dictionary, the two unigram tokens, ‘woman’ and ‘18’ were
removed from original data set and replaced with ‘woman_18’. Otherwise, the first two
tokens were kept, and the combination window for bigram slid to next token and
generated second possible bigram combination ’18 year’. All possible bigram
combination from clinical trial id ‘NCT01506700’ inclusion criteria were compared with
the custom dictionary and found one bigram match ‘invasive ductal carcinoma’ and
‘invasive lobular carcinoma’.
Table 15. All Bigram Combinations from NCT01506700 and
Results of the Custom Dictionary Matching

Inclusion /
Exclusion

All Bigram Combinations

Matching with
The Custom Dictionary

woman 18
18 year
year age
age older
older sign
Inclusion
Criteria

sign icf
icf woman
woman histologically
histologically diagnose
diagnose breast
breast prior

partial mastectomy
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prior surgery
surgery Planning
Planning breast
breast preservation
preservation patient
patient undergo
undergo lumpectomy
lumpectomy partial
partial mastectomy
mastectomy procedure
multicentric disease
disease histologically
histologically diagnose
diagnose cancer
cancer two
two different
different quadrant
quadrant breast
breast neoadjuvant
neoadjuvant systemic
Exclusion
Criteria

systemic therapy
therapy t4
t4 tumor
tumor previous
previous radiation
radiation operate
operate breast
breast prior
prior surgical
surgical procedure
procedure same

systemic therapy
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same quadrant
quadrant implant
implant operate
operate breast
breast pregnancy
pregnancy Lactation
Lactation participate
participate investigational
investigational study
study drug
drug device
device influence
influence collection
collection valid
valid datum
datum under
under study

3.4.4. Matching with the UMLS Semantic Network
Semantic-Based Feature Expansion Using UMLS
Identifying optimal feature sets is crucial for improving the effectiveness of text
analysis (Chung 2009). There are two main research approaches to identifying optimal
feature sets for text analysis. The focus of the first approach is on feature selection and
extraction from relatively large documents. Usually, studies with a large corpus are
concerned with reducing feature sets efficiently to identify the optimal feature sets that
improve performance. The second approach focuses on expanding feature sets to find the
optimal feature set that enhances performance. This approach utilizes relatively small
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feature sets from small size documents and expands the features sets by adding
semantically related features (Chung, 2009).
Tso et al. (2003) proposed a method of feature expansion to resolve the data
sparseness problem, which is one of the most serious obstacles in research on word sense
disambiguation (WSD). The experiment of using a word sense identifier with a feature
expansion resulted in more than double the precision improvement over the baseline
approach alone (Tso et al., 2003). A prior study (Chung, 2009) showed that expanded
feature sets containing synonymous relationships significantly improved the results of
text categorization. When expanding feature sets with synonyms used on classifier
names, the effectiveness of text categorization considerably improved, regardless of word
sense disambiguation (Chung, 2009). Fisher and Roark (2007) incorporated feature
expansion techniques into their sentence-ranking framework and achieved substantial
gains over the baseline framework, which does not include feature expansion steps.
Document representation through the simple BOW vector space model has a few
shortcomings such as ignoring term dependencies, structure, and ordering of the terms in
documents. To overcome these issues, Khan (2010) proposed Semantics Based Feature
Vector using Part of Speech (POS) tags to extracts the concept of terms in feature set.
Also, he used WordNet to extracts co-occurring and associated terms. The proposed
method outperformed the TF-IDF with BOW feature selection method for text
classification.
There have been several attempts to incorporate semantic features from the
WordNet lexical database to improve the predictive performance of the text classification
model (de Buenaga Rodriguez et al., 1997; Scott and Matwin, 1998; Jensen and Marinez,
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2000; Kehagias et al., 2003; Hotho and Bloehdorn, 2004; Rosso et al., 2004; Peng and
Choi, 2005; Mansuy and Hilderman, 2006). The rationale behind this is that the features
in the training set alone are not enough to build a good model for categorization.
However, if we incorporate the word relationships from WordNet, a more accurate model
may be possible. Most prior studies reported that incorporating semantic features results
in a statistically signiﬁcant increase in accuracy (Mansuy and Hilderman, 2006).
The clinical trial eligibility criteria section is not a lengthy document but is a
succinct description of clinical trial subject characteristics. Moreover, the contents in the
clinical trial eligibility criteria are written by medical researchers, and the target audience
are also medical experts; thus, the criteria usually include a large number of medical
terms. For that reason, I incorporated synonymously related terms from the UMLS
Semantic Network to expand feature sets based on semantic relatedness.
All trigram and bigram terms that were found in the custom dictionary were
passed on to the next step to find synonyms from the UMLS Semantic Network. I created
a custom query to find all synonymous relationships in the UMLS Semantic Network and
then ran the custom query with each trigram and bigram term.
Table 16 shows the UMLS synonym matching results for each trigram and bigram
term, and Table 17 shows the final feature set for clinical trial NCT01506700.
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Table 16. UMLS Synonym Matching Result for NCT01506700

Inclusion /
Exclusion

Trigrams and Bigrams
Found in Custom Dictionary

Matching UMLS Synonyms

invasive ductal carcinoma

No Match

invasive lobular carcinoma

No Match
Subtotal mastectomy

Inclusion
Criteria

Segmental excision of breast
partial mastectomy

Excision of part of breast
Partial mastectomy
Segmental resection of breast
Segmental excision of breast

Exclusion
Criteria

systemic therapy

No Match

Table 17. Final Feature Set for NCT01506700

woman 18 year age older sign icf woman histologically
diagnose invasive_ductal_carcinoma
invasive_lobular_carcinoma breast prior surgery Planning breast
Inclusion

preservation patient undergo lumpectomy partial_mastectomy
procedure Subtotal_mastectomy Segmental_excision_of_breast
Excision_of_part_of_breast Segmental_resection_of_breast
multicentric disease histologically diagnose cancer two different
quadrant breast neoadjuvant systemic_therapy t4 tumor
previous radiation operate breast prior surgical procedure same

Exclusion

quadrant implant operate breast pregnancy Lactation participate
investigational study drug device influence collection valid
datum under study
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To the best of my knowledge, there has been no study that applies the semanticbased feature expansion technique to clinical trial clustering. This is the first study that
adopts novel approaches that can improve text analysis performance for clinical trial
subject eligibility clustering.

3.4.5. Hierarchical Clustering
Classification and clustering are two different types of data mining problems
(Dunham, 2003). Also, they are two typical examples of supervised and unsupervised
data mining.
Given a set of objects that is partitioned into a finite set of classes, classification is
the task of automatically determining the class of an unseen object, based typically on a
model trained on a set of objects with known class memberships. Clustering is the
process of grouping data objects together on the basis of the features they have in
common. The objects are grouped into clusters with the objective of maximizing the
intra-cluster similarity and the inter-cluster dissimilarity between objects.
Classification is supervised in that it typically requires labeled training data to
train a classifier. The categorization or automatic classification of texts is the task of
distributing a set of documents according to some common characteristics. The terms
“categorization” or “classification” are used when dealing with the assignation of a
document to a predefined classes or categories.
Clustering is unsupervised since it is performed on raw input data with no prior
knowledge, or supervision, over method. Unsupervised classification or "clustering" is
automatic and discovers latent (hidden) unlabeled classes. The term “clustering”
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designates the creation of classes or groups (clusters) of a certain number of similar
objects without prior knowledge. The classes are isolated from one another and are
discovered automatically. A large number of unsupervised classification methods have
been applied to textual documents (Amine et al., 2008).
Hierarchical clustering is the clustering in which the clusters do not simply make
a partition of the set of objects, but the set of objects are organized into a tree hierarchy
so that any child cluster is a subset of the parent cluster and the sibling clusters are
disjoint. When applied to genomes, hierarchical clustering produces a biological
taxonomy, which helps us to make sense of the enormous diversity of living organisms.
In any organism, there are many different kinds of features to choose from, and in
principle, all of them can be used. Unsupervised learning is one of the main strengths of
the hierarchical clustering methodology, and its high performance becomes even more
significant when compared to some supervised methods.

Similarity Measure
Typically, the similarity between documents is estimated by a function calculating
the distance between the vectors of these documents. Two documents that are close
according to this distance are regarded as similar. Several measures of similarity have
been proposed (Jones and Furnas, 1987), including the following:
Cosine distance:
cos ,  =
Euclidean distance:

∑  ! × #$!( ,  )% ·  ! × #$!( ,  )%
‖ ‖( · ‖ ‖(
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Euclidean ,  = )∑*+ , 

(

Manhattan distance:

Manhattan ,  = ∑*+, ,  ,

The main purpose of this essay is to cluster clinical trials with semantic based
feature expanded subject eligibility criteria. There are a number of clustering models
based on connectivity, centroid, distribution, and other characteristics. In this experiment,
the agglomerative hierarchical clustering model was adopted because it could show all
the merging steps in the clustering process. To measure similarity between clinical trial
subject eligibility, I adopted the cosine distance, which is one of the popular metrics for
text analysis.

3.5. Results
Before conducting the hierarchical clustering analysis, the scatter score for all
clusters was calculated to determine the optimal number of clusters. Scatter score
measures the degree of within-cluster scatter for the specified clusterings with the
specified distance. The within-cluster scatter is simply the sum of the scatters for each set
in the clustering. As the number of clusters increases, the within-cluster scatter decreases
monotonically. Typically, this is used to determine how many clusters to generate by
inspecting a plot of within-cluster scatter against the number of clusters and looking for a
"knee" in the graph.
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Figure 9 shows the scatter score for the all inclusion criteria set and the "knee"
point of the graph, which is 156. Therefore, the optimal number of inclusion criteria
clusters is 156.

Knee Point
(156)

Figure 9: Scatter Score for All Inclusion Criteria Clusters

Figure 10 shows the scatter score for the all exclusion criteria set and the ‘knee’
point of the graph, which is 168. Therefore, the optimal number of inclusion criteria
clusters is 168.
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Knee Point
(168)

Figure 10: Scatter Score for All Exclusion Criteria Clusters

Based on the scatter score analysis, I generated 156 clusters for inclusion criteria
and 168 clusters for exclusion criteria. Figure 11 shows the sample of two clinical trials
inclusion criteria (NCT01642511 and NCT01668914) that clustered together at a low
level because the similarity score is 1.0. Table 18 shows the original eligibility inclusion
criteria of NCT01642511 and NCT01668914.
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Figure 11. Tree of Hierarchical Clustering for NCT01642511 and NCT01668914

Table 18. Original Text of Two Clinical Trials (NCT01642511 and NCT01668914)

CT ID

NCT01642511

NCT01668914
Similarity Score =1.0

- enlarged internal mammary nodes
Original
by imaging
Text

- enlarged internal mammary nodes
by imaging

Figure 12 shows the sample of two clinical trials exclusion criteria
(NCT01510964 and NCT01691144) that merged at a high level because the similarity
score was 0.56. Table 19 shows the original eligibility exclusion criteria of
NCT01510964 and NCT01691144.

Figure 12. Tree of Hierarchical Clustering for Exclusion Criteria
(NCT01510964 and NCT01691144)
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Table 19: Original Text of Two Clinical Trials for Exclusion Criteria
(NCT01510964 and NCT01691144)

CT ID

NCT01510964

NCT01691144
Similarity Score =0.56

Original
Text

- presence of metastasis or
relapse
- severe mental
deterioration
- comprehension difficulties of
the Italian language.

- Unability to fill out questionnaires
(due to language or cognitive barriers)

Table 20 shows other examples of case comparison by the inclusion criteria similarity score.
Table 20. Example of Case Comparison
Case No.

NCT01619306

Contents

Inclusion Criteria:
- Patients with early
stage breast cancer
- Healthcare
professionals caring for breast cancer patients
- Medical students /cancer researchers

Case No.

Contents

NCT01619514

Inclusion Criteria:
cancer

- Patients with breast

NCT01506869

Phase 1
Inclusion Criteria:
1.
Age >= 40 years old
2. Gender: males
and females
3. Provide written informed
consent
4. Satisfactory compliance
Phase 2
Inclusion Criteria:
1.
Age >= 40 and =< 75 years old
2.
Gender: males and females
3. Provide
written informed consent
4. Satisfactory
compliance
Exclusion Criteria:
1.
History of cancer;
2. History of LADA
and other autoimmunity diseases;
3.
Acute diabetic complication, acidosis, etc;
4. Moderate to severe liver, kidney
dysfunction, i.e. ALT/AST > 2.5 times the
upper
limit of normal range or Ccr <
25ml/min;
5. Any other condition or
major systemic diseases that the investigator
feels would
interfere with trial
participation or evaluation of results.

Score
0.88

0.09
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NCT01526499

NCT01526512

Inclusion Criteria:
1. Females with age
between 18 and 80 years old
2. ECOG
performance between 0-3
3. Life
expectancy more than 3 months
4.
Histological proven unresectable recurrent or
advanced HER2-negative breast cancer
5. At least one previous therapy regimen
(including endocrine therapy) for metastatic
breast cancer;suitable for monotherapy
(Neoadjuvant or adjuvant docetaxel should be
completed at least one year).
6. At least
one measurable disease according to the
response evaluation criteria in
solid
tumor (RECIST1.1)
7. No anticancer
therapy within 4 weeks
8. Adequate
hematologic, hepatic, and renal function,No
serious medical history of
heart, lung,
liver and kidney
9. Provision of written
informed consent prior to any study specific
procedures
10. Previous capecitabine is
permitted, however, it should be completed at
least 6
months.
Exclusion
Criteria:
1. Pregnant or lactating women
(female patients of child-bearing potential must
have a
negative serum pregnancy test
within 14 days of first day of drug dosing, or, if
positive, a pregnancy ruled out by ultrasound)
2. Women of child-bearing potential, unwilling
to use adequate contraceptive protection

0.97
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Inclusion Criteria:
1. Females with age
between 18 and 70 years old
2. ECOG
performance between 0-1
3. Life
expectancy more than 3 months
4.
Histological proven unresectable recurrent or
advanced breast cancer
5. No previous
chemotherapy for metastatic breast
cancer;suitable for monotherapy
(Neoadjuvant or adjuvant docetaxel should be
completed at least one year).
6. At least
one measurable disease according to the response
evaluation criteria in
solid tumor
(RECIST1.1)
7. No anticancer therapy
within 4 weeks
8. Adequate hematologic,
hepatic, and renal function,No serious medical
history of
heart, lung, liver and kidney
9. Provision of written informed consent prior to
any study specific procedures
Exclusion
Criteria:
1. Pregnant or lactating women
(female patients of child-bearing potential must
have a
negative serum pregnancy test
within 14 days of first day of drug dosing, or, if
positive, a pregnancy ruled out by ultrasound)
2. Women of child-bearing potential, unwilling
to use adequate contraceptive protection
during the course of the study
3.
Treatment with an investigational product within
4 weeks before the first treatment
4.
Symptomatic central nervous system metastases

5. Other active malignancies (including other
hematologic malignancies) or other
malignancies, except for cured nonmelanoma
skin cancer or cervical intraepithelial
neoplasia.
6. Patient having a history of
clinically significant cardiovascular, hepatic,
respiratory or renal diseases, clinically
significant hematological and endocrinal
abnormalities, clinically significant neurological
or psychiatric conditions
7. Uncontrolled
serious infection
8. Patients with bad
compliance

during the course of the study
3.
Treatment with an investigational product
within 4 weeks before the first treatment
4. Symptomatic central nervous system
metastases
5. Other active malignancies
(including other hematologic malignancies) or
other
malignancies, except for cured
nonmelanoma skin cancer or cervical
intraepithelial
neoplasia.
6.
Patient having a history of clinically significant
cardiovascular, hepatic,
respiratory or
renal diseases, clinically significant
hematological and endocrinal
abnormalities, clinically significant
neurological or psychiatric conditions
7.
Uncontrolled serious infection
8.
Patients with bad compliance
9. Patients
lack of Dihydropyrimidine
Dehydrogenase(DPD)
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NCT01558258

Inclusion Criteria:
- women diagnosed
with early, resectable breast cancer (Stage 0, I, II,
or III) prior
to age 50
- have
completed treatment with surgery, radiation,
and/or chemotherapy at least 3
months
previously.
Exclusion Criteria:
have a breast cancer recurrence, metastasis, or
another cancer diagnosis (excluding
nonmelanoma skin cancer
- unable to commit
to intervention schedule.

0.07

NCT01627366

Inclusion Criteria:
- Female
- 21
years of age or older
- English- or
Spanish-speaking
- Diagnosis of ductal
carcinoma in situ (DCIS) or Stage I, II, or III
BC for the first
time
- 12
months post-diagnosis
- At least 1
month post-chemotherapy completion
Exclusion Criteria:
- Previous cancer
except non-melanomatous skin cancers or in
situ non-breast cancers
- Pregnant and
lactating women
- Patients receiving
parenteral anti-cancer therapy, except
trastuzumab
- Clinically apparent
cognitive or psychiatric impairment
-

0.59
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NCT01569802

Inclusion Criteria:
- Subject is female
of any race and ethnicity
- The subject
is asymptomatic and presents for routine
screening mammography and
chooses
to have a combination 2D + 3D mammogram
as her standard of care.
Exclusion
Criteria:
- Patient chooses standard 2D
mammography over a combination 2D + 3D
mammogram

Participation in another research study
Current treatment for another cancer
Male

NCT01569802

-

Inclusion Criteria:
- Subject is female
of any race and ethnicity
- The subject
is asymptomatic and presents for routine
screening mammography and
chooses
to have a combination 2D + 3D mammogram
as her standard of care.
Exclusion
Criteria:
- Patient chooses standard 2D
mammography over a combination 2D + 3D
mammogram

0.01
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3.5.1. Intersection of inclusion and exclusion clusters
Since the inclusion and exclusion subject eligibility criteria were mutually
exclusive, the eligibility criteria section was divided into two sub-sections: inclusion
criteria and exclusion criteria. The two data sets were pre-processed, matched with the
custom dictionary and UMLS Metathesaurus, and clustered individually. However, to
achieve completed clinical trial subject eligibility clusters, it was necessary to merge the
two different cluster sets.
All the elements in each inclusion cluster were compared with all the elements in
each exclusion cluster and new clusters were generated based on only the elements
belonging to the same inclusion and exclusion clusters. Figure 13 presents an example of
new cluster generation. For instance, clinical trials A, B, C, and D belong to the inclusion
cluster Inc-I, and clinical trials A, B, E, D, and F belong to the exclusion cluster Exc-I.
From this example, the new cluster Inc-I is created that includes only the common
elements of the inclusion cluster Inc-I and the exclusion cluster Exc-I. More specifically,
when we assume that one of the criteria in the inclusion cluster Inc-I is subject’s
pregnancy and one of the criteria in the exclusion cluster Exc-I is subject’s breast
feeding, the intersection cluster of the inclusion cluster Inc-I and the exclusion cluster
Exc-I will have the eligibility criteria that include subjects who are pregnant but exclude
those who are breastfeeding.
As mentioned before, the total number of inclusion clusters was 156 and the total
number of exclusion clusters was 168. From these clusters, 596 intersection clusters were
generated. Accordingly, the number of intersection clusters that had more than two
instances was 117, and the number of intersection clusters with two or less than two
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instances was 479. Table 21 presents the number of intersection clusters. The name for an
intersection cluster was assigned by combining the ID of the inclusion cluster and the
exclusion cluster. For example, the intersection cluster Inc(16)_Exc(130) had clinical
trials that appeared in both inclusion cluster(16) and exclusion cluster(13).

Table 21. Number of Intersectional Clusters

Number of Clusters

Total number of intersection clusters

596

Number of single-instance clusters

393

Number of two-instance clusters

86

Number intersection clusters
having more than two instances

117

78

Figure 13. Intersection Clusters of the Inclusion and Exclusion Clusters
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3.6. Cluster labeling
3.6.1. UMLS Synonym chunks
Identifying most frequent synonym chunks in clusters
To identify the characteristics of clusters, I generated a label for each cluster.
First, I counted all the synonym chunks that were used for the semantic feature expansion
in inclusion and exclusion criteria from same intersection clusters. The most frequent
synonym chunk of the inclusion and exclusion clusters was selected as the representative
label for the intersection cluster. If the most frequent synonym chunk in the inclusion or
exclusion cluster had been already selected for another intersection cluster, the second
most frequent synonym chunk was selected. If multiple most frequent synonym chunks
with the same frequency are found, all of the synonym chunks in the top frequency were
selected for labeling.
Next, I queried UMLS Metathesaurus with selected inclusion and exclusion
synonym chunks to find the lowest concept unique identifier among synonyms. The CUI
in UMLS is the concept unique identifier for a UMLS Metathesaurus concept to which
strings with the same meaning are linked. The synonyms in chunks has their own CUI.
To find unique name of each synonym chunk, I used lowest CUI in each synonym chunk.
Then, all the lowest CUI concepts from UMLS Metathesaurus are merged and the
‘|’ symbol is added between concepts as a delimiter. Also, ‘||’ is added to divide inclusion
and exclusion synonym chunks.
Table 22 presents the proposed label for the intersection cluster
Inc(16)_Exc(130). For the Inc(16)_ExC(13) cluster, the lowest CUI of the most frequent
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synonym chunk in inclusion section is C0013216 and the note for C0013216 are
‘Chemotherapy’ and ‘Drug therapy’. The lowest CUI of the most frequent synonym
chunk in exclusion section is C0006141 and the notes for C0006141 are ‘Breast
anatomy’, ‘Breast’ and ‘Breast structure’. The proposed label for Inc(16)_Exc(130) is
merging the notes for these two sections, ‘CT - Chemotherapy|Drug
therapy|Chemotherapy|DT - Drug therapy||Breast anatomy|Breast|Breast structure’. The
proposed label means that representative inclusion criteria for intersection cluster
Inc(16)_Exc(130) are ‘Chemotherapy’ and ‘Drug therapy’. The representative exclusion
criteria for intersection cluster Inc(16)_Exc(130) are ‘Breast anatomy’, ‘Breast’ and
‘Breast structure’. All the trials in intersection cluster Inc(16)_Exc(130) require
‘Chemotherapy’ or ‘Drug therapy’ experience for patients as inclusion criteria, and the
patient experienced ‘Breast anatomy’ should be excluded all trials in intersection cluster
Inc(16)_Exc(130).

Table 22. Proposed label for the cluster Inc(16)_Exc(130)

Intersection Cluster ID
Inc(16)_Exc(130)

Label
CT - Chemotherapy|Drug therapy|Chemotherapy|DT Drug therapy||Breast anatomy|Breast|Breast structure

Table 23 shows the algorithm to generate labels for the intersectional clusters.
First, all the UMLS synonym chunks were counted for all the inclusion and exclusion
clusters. Second, the most frequent synonym chunk in each inclusion and exclusion
cluster was selected as a candidate for label. If there were more than two synonym
chunks in one cluster in the same frequency, all the synonym chunks were selected. If the

81
most frequent synonym chunk had been already selected for another cluster, the second
most frequent synonym chunk was the selected candidate. Third, the synonym chunk for
inclusion and exclusion was merged to generate the full label. If inclusion and exclusion
synonym chunks were the same, I selected the second most frequent synonym chunk for
the exclusion cluster.

Table 23. Pseudo Code for generating cluster label

Function GenerateIntersectionClusterLabel(ClusterID) : returns ClusterLabel
Begin
Set ClusterLabel to null
Set ClinicalTrials to null
Set SynonymInclusion to null
Set SynonymExclusion to null
Set MostFrequentSynonymsInInclusion
Set MostFrequentSynonymsInExclusion
Set SynonymCount to 0
Create Queue, Q
Query DB AllClinicalTrials in ClusterID
Add AllClinicalTrials to Q
While Q is not empty
De-queue AllClinicalTrials CT from Q
For each CT in AllClinicalTrials
Query DB Synonym in CTInclusion
Count SynonymInclusion
For each Synonym in CTInclusion
If CountIncSynonym >= MostFrequentSynonymsInInclusion
and LowesetCUIIncSynonym is not exist in Label list
MostFrequentSynonymsInInclusion = SynonymInclusion
Qeury DB newLowestCUI in UMLS
Add ClusterLabel
Else If
Break
End If
Next
Query DB Synonym in CTExclusion
Count SynonymExclusion
For each Synonym in CTExclusion
If CountExcSynonym >= MostFrequentSynonymsInExclusion
and LowesetCUIExcSynonym is not exist in Label list
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MostFrequentSynonymsInExculision = SynonymExclusion
Qeury DB newLowestCUI in UMLS
Add ClusterLabel
Else If
Break
End IF
Next
Next
End While
Return ClusterLabel
End

The clinical trial NCT01202851 belongs to the intersection cluster
Inc(16)_Exc(130). Table 24 presents the original text of the subject eligibility section in
NCT01202851; it has ‘adjuvant radiation’ in the inclusion criteria and ‘surgical
treatment’ in the exclusion criteria, both corresponding to the proposed label.

Table 24. Subject Eligibility of NCT01202851

CT ID

NCT01202851

Subject Eligibility Text
Inclusion Criteria:
1. Women with stage 0 - III
breast cancer who will be undergoing daily adjuvant
radiation for 4-6 weeks (patients only).
2. 18
years of age or older (patient and spouse/partner).
3. Able to read, write, and speak English or Spanish
(patient and spouse/partner).
Exclusion Criteria:
1. Patients who have any major psychiatric diagnoses
(e.g., schizophrenia, bipolar
disorder).
2.
Patients who have not undergone any surgical
treatment for their cancer.
3. Patients with
extreme mobility issues (e.g., unable to get in and out of
a chair
unassisted).
4. Patients who have
practiced yoga or taken yoga classes in the year prior to
study
enrollment or who are currently engaged
in a regular mind-body practice
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3.7. Discussion
The broad objective of this work was to group and summarize clinical trial subject
eligibility using a hierarchical clustering approach. This essay has also presented a
framework for clustering clinical trial and labeling clusters.
In this research, I examined 1,660 breast cancer clinical trials and derived 596
intersectional clusters. Also, I generated a label for each cluster to identify the
characteristics of the cluster. The full text information of clinical trial studies were
collected from ClinicalTrials.gov, and the original XML format documents were parsed
with the author-developed parser. The subject eligibility section was extracted from the
parsed documents and it was divided into two data sets for inclusion and exclusion
criteria.
The agglomerative hierarchical clustering algorithm with cosine similarity metric
was used to generate two sets of clusters, one for inclusion and the other for exclusion
criteria; sets and intersection clusters were derived from those two cluster sets. The
cluster labels were generated based on the most frequent UMLS synonym chunks in each
inclusion and exclusion cluster to understand the characteristics of clusters.
While healthcare and IS researchers have made substantial progress in clustering
clinical trial subject eligibility, little has been done to examine the semantic feature
expansion technique in the healthcare domain and the contrary characteristics of
inclusion and exclusion criteria. Inclusion criteria should be found and exclusion criterial
should not be found in patient records.
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This essay has also made practical contributions by providing groups of similar
clinical trials that can reduce a physician’s search space to find relevant trials to help
clinical trial research as well as to provide alternative treatment to terminal disease
patients.
The clusters can also be utilized by initiators of new clinical trial study for finding
similar trials currently in progress. When a primary investigator starts a new clinical
research study, he or she is required to review all the relevant prior clinical studies. The
clusters from this study can reduce the cost and effort for future clinical trial researchers
by providing clinical trial clusters that have been labeled with the main features.
Furthermore, the total number of clinical trials is increasing, and research in the
healthcare domain is becoming more competitive. A clinical study usually requires a
huge amount of resources with respect to financial support, expert involvement, and
subject participation. Therefore, repeating the same type of clinical study should be
avoided; each study should have its unique contributions. The clusters from this research
could be exploited for finding research on similar topics and help to screen research
topics that have been already conducted by other researchers. Furthermore, when a new
trial study is proposed, the primary investigator usually estimates the required number of
subjects. The cluster information can provide a similar trial group, and the primary
investigator can use that to identify other trials that are looking for similar patients. In this
vein, clinical trial cluster information enables for researchers to estimate probability of
successful recruitment of required number of participants.
There are several ways in which future research could strengthen the results of
this study. First, this research was confined to the breast cancer domain. Future studies
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could investigate the proposed framework in the context of different kinds of diseases. I
used the hierarchical clustering algorithm and applied the cosine theta as the document
similarity metric. However, prior studies have proposed different approaches for
clustering and document similarity metrics. For example, Latent Dirichlet allocation
(LDA), latent semantic indexing, independent component analysis, probabilistic latent
semantic indexing, non-negative matrix factorization, and Gamma-Poisson distribution
techniques have been used in bioinformatics research. These new techniques could be
applied in future research.
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CHAPTER 4
Essay 3: Automatic Matching Process of
Clinical Trials Subject Recruitment

“With enough information, it is almost impossible ‘not’ to predict people's action.”
Idries Shah

4.1. Introduction
About 85% of people with cancer were either unaware or unsure that participation
in clinical trials was an option, although about 75% of these people said they would have
been willing to enroll had they known it was possible (Harris Interactive, 2001). Previous
research by UC Davis Cancer Center (UC Davis Cancer Center, 2001) investigators,
published in 2001 in the Journal of Clinical Oncology, found that both doctors and
patients sometimes hold misconceptions that can discourage enrollment in clinical trials.
In the UC Davis Cancer Center study, more than one third of the doctors declined to refer
patients to clinical trials, mistakenly believing that no trials were available. In reality,
more than 150 clinical trials were available during the study period.
Another common barrier of clinical trial participation is distrust or suspicion
about research. This is despite the fact that many investigational treatments are at least as
effective as conventional therapy, and cancer patients who participate in clinical trials
frequently have higher survival rates than those who receive standard care (UC Davis
Cancer Center, 2001). Because of this unwarranted distrust or suspicion, four out of ﬁve
clinical trials are delayed, and 50% of the delays are due to participant recruitment
challenges (Patel et al., 2010).
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These low rates represent a significant barrier to speeding progress in cancer
treatment by delaying the dissemination of new therapies. Low participation in clinical
trials is a critical issue in healthcare research, where participation rates range between 5%
and 10% for most trials (Patel et al., 2007). In the domain of oncology, for example,
fewer than 3% of potentially eligible patients enroll in clinical trials, and patient
enrollment for clinical trials is as low as 2% of the patient recruitment goal (Embi et al.,
2005).
Although the cost of running trials is now approaching 30% of pharmaceutical
companies’ entire drug development budgets, 75% of patient studies fail to make their
timelines, often causing expensive delays in regulatory approval and market launch. Also,
testing on humans is a sensitive and a difficult issue as it involves many legal and ethical
issues. Difficulties in patient recruitment are the major reason for failure of clinical
research (Spilker and Cramer, 1992).
Low and slow recruitment has serious negative impacts on the translation of the
clinical trial results. It could produce inadequate statistical analyses of outcomes, lead to
premature closure of trials, delay trial duration, incur higher costs of drug production, and
cause loss of accreditation of the research institution that performs these studies
(Penberthy et al. 2010).
Patient and physician factors can also be barriers to the enrollment in clinical
trials (Breitfeld et al. 1999). Patient factors include lack of access to a healthcare institute
offering clinical trials, economic and social barriers, and attitudes and beliefs. Among the
diverse reasons physicians may fail to offer clinical trial participation to patients is lack
of time. For example, to determine whether new patients may be eligible for a clinical
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trial, physicians need to search multiple clinical trial repositories and read through the
eligibility sections of several protocol documents. Physicians who participate in a busy
oncology practice may find that they do not have sufficient time to do this and identify
eligible subjects efficiently. Their lack of time for these activities, which may interrupt
the flow of patients, constitutes a substantial barrier to trial enrollment. They may also
simply forget to offer and enroll patients in possible trials.
Determining the eligibility of every patient is the first step in assuring adequate
and unbiased clinical trial research. Yet, not all eligible patients are evaluated or invited
to participate in a clinical trial despite the fact that patients who are offered a trial are
likely to participate (Albrecht, 2008). One of the major impediments to participation is
that this process of matching a patient to a clinical trial is manual and physician-driven.
Traditionally, in this process, clinical trial research staff manually review multiple
clinical data sources from patient medical records and match them with subject eligibility
criteria. Eligible patients are often missed by this manual review process (Penberthy,
2010). Thus, helping identify potentially eligible subjects increases the likelihood of
patient participation in a clinical trial and is critical to the issue of under-representation.
In this essay, I propose a novel framework for clinical trial subject recruitment
using NLP and text mining techniques for automating the clinical trial and subject
matching process, which is currently labor intensive and error prone. The proposed
approach could be very helpful for expediting and improving the clinical trial subject
recruitment process.
The rest of the chapter is organized as follows. The literature review that serves as
the overview of research stream in patient and clinical trial matching is presented in
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section 4.2. Document similarity measurement techniques underlying the patient and
clinical trial matching process, as well as the entire research framework, are presented in
sections 4.3 and 4.4. Section 4.5 presents the matching and evaluation results. Section 4.6
discusses the implications, limitations, and future directions of this research.

4.2. Background Literature
Table 25 presents the selected research on matching clinical trials and patient information.
Table 25. Selected research on matching clinical trials and patient information
Authors

Patel et al.

Patel et al.

Journal

Title

Topic / Research
Question

Theory/ Model

Data

IBM Research
(2007)

Matching Patient Records to
Clinical Trials Using
Ontologies

Case study for
clinical trial subject
selection using
ontologies and
semantic
technology

Elsevier (2012)

TrialX: Using semantic
technologies to match patients
to relevant clinical trials based
on their Personal Health
Records

TrialX, a consumercentric tool that
matches patients to
clinical trials

Effect of a clinical trial alert
system on physician
participation in trial
recruitment

Evaluation of
electronic health
record based
clinical trial alert
system

4 month
intervention with
114 physicians

Pilot Study of a Point-of-use
Decision Support Tool for
Cancer Clinical Trials
Eligibility

Development of
point-of-use
portable decision
support tool (DSTRIEL) to
automate this
matching process

pilot-test with
academic medical
oncologist

Breitfeld et al.

Journal of the
American
Medical
Informatics
Association
(1999)

SNOMED CT,
One year patient
data from
Columbia
Medical Center

The CTA
intervention was
associated with
significant
increases in
physicians’ referrals
and enrollments
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Embi et al.

American
Medical
Association
(2005)

Finding /
Implication

Authors

Brigitte Séroussi
and Jacques
Bouaud

Penberthy et al.

Journal

Artificial
Intelligence in
Medicine (2003).

Contemporary
Clinical Trials
(2010)

Title

Topic / Research
Question

Theory/ Model

Data

Finding /
Implication

Using OncoDoc as a
computer-based eligibility
screening system to improve
accrual onto breast cancer
clinical trials

Development of
OncoDoc decision
support system
designed to provide
best therapeutic
recommendations
for breast cancer
patients

Significantly
improved physician
compliance and
enhanced physician
awareness of open
trials.

Automated matching software
for clinical trials eligibility:
Measuring efficiency and
flexibility

A pilot project
evaluating the
efficiency,
flexibility, and
generalizability of
an automated
clinical trials
eligibility screening
tool

5 different
clinical trials and
clinical trial
scenarios.

Automation offers
an opportunity to
reduce the burden
of the manual
processes required
for CT eligibility
screening

187 past patients
and 74 current
patients for
Knowledge base
261 breast-cancer
patients for test

1800 clinical
trials

Fink et al.

Artificial
Intelligence in
Medicine (2004)

Selection of patients for
clinical trials: an interactive
web-based system

Development of a
web-based expert
system that assigns
cancer patients to
clinical trials

Korkontzelos et
al.

BMC Medical
Informatics and
Decision Making
(2012)

ASCOT: a text mining-based
web-service for
efficient search and assisted
creation of clinical
trials

ASCOT, clinical
trial search and
creation tool.
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There has been limited research on the topic of clinical trial and patient matching
process. Korkontzelos et al. (2012) presented ASCOT (Assisting Search and Creation Of
Clinical Trials), a clinical trial search application that employs text mining technology,
clustering, and term extraction algorithms.
Patel et al. (2010) published an article on the clinical trial and patient matching
process. In that paper, they introduced TrialX, a consumer-centric tool that matches
patients to clinical trials by extracting Personal Health Records (PHR) from Microsoft
HealthVault (MHV) and Google Health (GM), and linking patients to the most relevant
clinical trials using semantic web technologies.
Penberthy et al. (2010) evaluated the efficiency, flexibility, and generalizability of
a clinical trials eligibility screening tool with five different clinical trials. The results of
their study demonstrated that the automated tool could reduce the time and cost of the
manual processes required for clinical trial eligibility screening and assure clinical trial
participation opportunity. During the study period in evaluating patients for eligibility by
research staff, there was a substantial total savings ranging from 165 hours to 1,329
hours. The ratio of mean staff time for identifying eligible patients ranged from 0.8 to
19.4 for the manual versus the automated process.
In 2007, Patel et al. tried to formulate the clinical trial and patient matching
process as a problem of semantic retrieval. They focused on the applicability of
SNOMED CT ontologies, which define classes of disorders, drugs, and organisms. The
case study, conducted with one year of anonymized patient records from Columbia
University Medical Center, reported that using an ontology to automate the matching
process is feasible and practical. However, that research focused only on the ontology-
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based mapping. No text mining or NLP techniques were examined for the matching
process.
Embi et al. (2005) investigated the effects of an electronic health record (EHR)based clinical trial alert (CTA) system in selected outpatient clinics of a large US
academic healthcare system. CTA was tested during the subsequent 4-month intervention
period when a patient’s EHR data met selected trial criteria. One hundred fourteen
physicians practicing at selected EHR-equipped clinics participated in the study. The
researchers compared the number of physicians participating in recruitment and their
recruitment rates before and after CTA intervention. The results of the study showed that
CTA intervention was associated with significant increases in the number of physician
referrals and enrollment. However, Embi et al.’s research only focused on the evaluation
of CTA intervention, and the clinical trial eligibility matching was conducted by the
trial’s principal investigator.
Breitfeld et al. (1999) developed a point-of-use portable decision support tool
(DS-TRIEL) to automate the matching process. A two-level hierarchic decision
framework was used for the identification of eligible subjects for two open breast cancer
clinical trials.
Séroussi and Roland (1998) developed OncoDoc, which is a decision support
system designed to provide the best therapeutic recommendations for breast cancer
patients. OncoDoc is a browsing tool of a knowledge base, structured as a decision tree,
which allows physicians to control the contextual instantiation of patient characteristics
to build the best formal equivalent of an actual patient. It provides either evidence-based
therapeutic options or relevant patient-specific clinical trials.

94

Fink et al (2004) developed a rule-based expert system that helps assign patients
to clinical trials. The experiment results showed that their system can increase the
efficiency of the patient selection process.
There have been several research studies that developed expert systems for
helping select clinical trials for cancer and AIDS patients. Musen et al. (1996) built a
rule-based system, called EON, that matched AIDS patients to clinical trials.
Ohno-Machado et al. developed the AIDS2 system, which matched AIDS patients
to clinical trials (Ohno-Machado et al., 1993). The integrated logical rules with Bayesian
networks was used for the AIDS2 system, and the system helped decision-making with
incomplete data and to quantify the decision quality.
Bouaud et al. created ONCODOC, a cancer expert system that suggested
alternative clinical trials and allowed a physician to choose one of the alternatives
(Bouaud et al 1998, 2000). S´eroussi et al. used ONCODOC to evaluate usefulness of the
system at two hospitals and found that ONCODOC helped increase the number of
matched patients (S´eroussi et al. 1999, 2001)
Hammond and Sergot (1996) developed OaSiS, which has a graphical interface
for entering patient data and extending the knowledge base. Papaconstantinou et al.
(1998) developed a Bayesian system that selected clinical trials for cancer patients
(Papaconstantinou et al., 1998, Theocharous et al. 1996). Their system learned
conditional probabilities of medical test outcomes and evaluated the probability of a
patient’s eligibility for each trial. Learning accurate probabilities requires sufficient
medical records, but the available medical records were limited in volume. Moreover, the
underlying Bayesian network needs to be modified when a new clinical trial is added.
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Fallowfield et al. investigated physicians’ cancer patient selection process for
clinical trials, and compared manual and automatic selection (Fallowfield et al. 1997).
Their study showed that expert systems could improve clinical trial patient selection
accuracy. Carlson et al. (1995) conducted research on AIDS trials and showed that expert
systems could improve patient selection.
In this section, I reviewed selected research on clinical trial and patient matching
processes as well as decision support systems for clinical trial subject recruitment. Only a
few attempts have so far been made on using NLP and text mining techniques. However,
these studies only used basic level techniques or vaguely described the research process.
In this essay, I propose a novel approach for the clinical trial and patient matching
process using state-of-art NLP and text mining techniques.
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4.3. Background
Document Similarity Measurement
In the text mining and NLP fields, text similarity measurement plays an
increasingly significant role. It measures the similarity between words, sentences,
paragraphs, and documents. It is also an important component in tasks such as
information retrieval, text classification, document clustering, topic detection, text
summarization, word-sense disambiguation, automatic grading, and machine translation
(Gomaa and Fahmy 2013). Over the past few decades, a large number of studies on
measuring text and document similarity were conducted. Gomaa and Fahmy (2013)
partitioned this issue into three approaches: string-based, corpus-based, and knowledgebased.
There are two different types of similarity in words: lexical and semantic
similarity. If two words have a similar character sequence, these two words are similar
lexically. If two words have the same meaning or are used in the same context or the
same way, they are similar semantically. String-based algorithms are used for lexical
similarity, while corpus-based and knowledge-based algorithms are used for semantic
similarity.

String-Based Similarity Measures
A string metric measures similarity or dissimilarity (distance) between two text
strings for string matching or comparison. Figure 14 shows 14 algorithms of string-based
similarity measures; seven of them are character-based measures, while the other seven
are term-based distance measures.
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Figure 14. String-Based Similarity Measures (Gomaa and Fahmy 2013)
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The Longest Common SubString (LCS) algorithm is used to find the longest
string (or strings) that is a substring (or are substrings) of two or more strings. The
similarity between two strings is based on the length of contiguous chain of characters
that exist in both strings. The longest common substring of the strings "ABABC",
"BABCA", and "ABCBA" is string "ABC" of length 3. Other common substrings are
"A", "AB", "B", "BA", "BC", and "C". Table 26 shows an output of the LCS algorithm.

Table 26. Output of LCS algorithm

ABABC
|||
BABCA
|||
ABCBA

The problem definition for LCS can be described as follows.
Given two strings, S of length m and T of length n, find the longest strings that are
substrings of both S and T. A generalization of this problem is the k-common substring

problem. Given the set of strings S = {/0 , … , /2 } where |/ | = 5 and ∑ 5 = 6, find
each 2 ≤ 9 ≤ :, the longest string that occurs as substrings of at least k strings.

Damerau-Levenshtein distance counts the minimum number of operations

needed to transform one string into the other to measure the distance between two strings.
An operation is defined as an insertion, deletion, or substitution of a single character, or a
transposition of two adjacent characters. The Damerau–Levenshtein distance differs from
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the classical Levenshtein distance by including transpositions among its allowable
operations. The classical Levenshtein distance only allows insertion, deletion, and
substitution operations.
The Damerau–Levenshtein distance between two strings a and b is given by

;, (|<|, |=|) where:
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Jaro and Jaro–Winkler distance depend on the number and order of the common
characters between two strings; it takes into account typical spelling deviations. Jaro is
primarily used in the area of record linkage. Jaro–Winkler is an extension of Jaro
distance, and it uses a prefix scale, which gives more favorable ratings to strings that
match from the beginning for a set prefix length. The higher the Jaro–Winkler distance
for two strings is, the more similar the strings are. The Jaro–Winkler distance metric is
designed for short strings, such as person names. The score is normalized such that 0
equates to no similarity and 1 is an exact match.
Problem definition for Jaro distance and Jaro–Winkler distance can be described
as follows.
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The Jaro distance  of two given strings X0 and X( is
0,
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where m is the number of matching characters and t is the number of transpositions.
Jaro–Winkler distance uses a prefix scale p, which gives a more generous score to

strings that match from the beginning for a set prefix length l. Given two strings s0 and

s( , their Jaro–Winkler distance d] is:

] =  + ( ^1 −  )

Where  is the Jaro distance for strings X0 and X( . l is the length of common prefix at the
start of the string up to a maximum of four characters. p is a constant scaling factor for

how much the score is adjusted upwards because having common prefixes p should not
exceed 0.25, otherwise the distance can become larger than 1. The standard value for this
constant in Winkler's work is p = 0.1
The Needleman-Wunsch algorithm is an example of dynamic programming and
is used in bioinformatics to align protein or nucleotide sequences. It performs a global
alignment to find the best alignment over the entire of two sequences. The algorithm
basically divides the full sequence into a series of smaller problems and uses the solutions
for the smaller problems to reconstruct a solution to the larger problem. The Needleman–
Wunsch algorithm is widely used for optimal global alignment, when the two sequences
are of similar length and the global alignment is important.
The Smith-Waterman algorithm is another example of dynamic programming
and performs local sequence alignment. It performs a local alignment to find the best
alignment between two strings or nucleotide or protein sequences. It is useful for
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dissimilar sequences that are suspected of containing regions of similarity or similar
sequence motifs within their larger sequence context. The distinction of the Needleman–
Wunsch algorithm is that negative scoring matrix cells are set to zero, which renders the
local alignments visible.
Problem definition for Smith-Waterman algorithm can be described as follows.
_(>, 0) = 0, 0 ≤ > ≤ K
_(0, ?) = 0, 0 ≤ ? ≤ 5

_(>, ?) = K<`
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Where a, b = String over the Alphabet ∑, m = length(a), n = length(b), s(a, b) is a
similarity function on the alphabet, H(i, j) is the maximum similarity score between a
suffix of a[1…i] and a suffix of b[1…j], e is the gap scoring scheme.

An n-gram is a sub-sequence of n items from a given sequence of text. The n-

gram similarity algorithm compares the n-gram characters or words in two strings. Text
distance is calculated by dividing the number of same n-grams with maximal number of
n-grams.
Block Distance is also known as rectilinear distance, boxcar distance, absolute

value distance, g0 distance, city block distance, and Manhattan distance. It computes the

distance that would be traveled to get from one data point to the other if a grid-like path is
followed. The block distance between two items is the sum of the differences of their

corresponding components. The block distance, 0 , between two vectors p, q in an n-
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dimensional real vector space with fixed Cartesian coordinate system, is the sum of the
lengths of the projections of the line segment between the points onto the coordinate
axes.
Problem definition for block distance can be described as follows.
j

Where (^, h) are vectors

0 (^, h) = ‖^ − h‖0 = i|^ − h |
k0

^ = (^0 , ^( , … , ^j ) <5 h = (h0 , h( , … , hj )

Cosine similarity is a measure of similarity between two vectors of an inner
product space that measures the cosine of the angle between them. The cosine of 0° is 1,
and it is less than 1 for any other angle. Thus, it determines an orientation and not
magnitude: two vectors with the same orientation have a cosine similarity of 1; two
vectors at 90° have a similarity of 0; and two vectors diametrically opposed have a
similarity of -1, regardless of their magnitude. Cosine similarity is generally used in
positive space, so the outcome is bounded within 0 and 1. One of the reasons for the
popularity of cosine similarity is that it is very efficient to evaluate.
Cosine similarity can be derived by using the Euclidean dot product formula.
< ∙ = = ‖<‖‖=‖ cos(m)

Given two vectors of attributes, A and B, the cosine similarity, cos(θ), is represented
using a dot product and magnitude as
X>K> <W>n = cos(m) =

∑jk0 o × p
o∙p
=
‖o‖‖p‖
q∑jk0(o )( × q∑jk0(p )(

Dice’s coefficient is defined as twice the number of common terms in the
compared strings divided by the total number of terms in both strings. Dice’s coefficient

103

retains sensitivity in more heterogeneous data sets and gives less weight to outliers.
Recently it has become popular in computer lexicography for measuring the lexical
association score of two given words.
Definition of Dice’s coefficient can be described as follows.

where (o, p) are binary vectors

/r =

2|o ∙ p|
|o|( + |p|(

o = (<0 , <( , … , <j ) <5 p = (=0 , =( , … , =j )

Euclidean distance or L2 distance is the "ordinary" distance between two points
in Euclidean space and can be described as the square root of the sum of squared
differences between corresponding elements of the two vectors. It can be described as
follows.
j

(^, h) = (h, ^) = q(h0 − ^0 )( + (h( − ^( )( + ∙∙∙ + (hj − ^j )( = si(h − ^ )(
k0

where p and q are Euclidean vectors.

Jaccard similarity, also known as the Jaccard index, is used for comparing the
similarity and diversity of sample sets. It is computed as the number of shared terms over
the number of all unique terms in both strings. It can be described as follows.
t(o, p) =

|o ∩ p|
|o ∪ p|

Where 0 ≤ J(o, p) ≤ 5 and if A and B are both empty, we define J(A,B) = 1.

104

Matching coefficient, also known as Simple Matching Coefficient (SMC), is a
vector-based approach that simply counts the number of similar terms or dimensions, on
which both vectors are non-zero. Given two objects, A and B, each with n binary
attributes, SMC is defined as follows.
/ax =

6yK=VW G a<bℎ>5 oW>=yVX
azz + a00
=
6yK=VW G oW>=yVX
azz + az0 + a0z + a00

Overlap coefficient, also known as Szymkiewicz-Simpson coefficient, is similar
to the Jaccard index but considers two strings a full match if one is a subset of the other.
It is defined as the size of the intersection divided by the smaller of the size of the two
sets. Overlap coefficient is defined as follows.
{VW <^(|, }) =

|| ∩ }|
min(|||, |}|)

Corpus-Based Similarity Measures
Corpus-based similarity is a semantic similarity measure that determines the
similarity between words according to information gained from large corpora. A corpus,
which is a large collection of written or spoken text data, is required to compute corpusbased similarity. Figure 15 shows the algorithms for corpus-based similarity measures.
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Figure 15. Corpus-Based Similarity Measures (Gomaa and Fahmy 2013)
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Hyperspace Analogue to Language (HAL) creates a semantic space from word
co-occurrences. The basic premise that HAL relies on is that words with similar meaning
repeatedly occur closely (i.e., co-occurrence). For example, in a large corpus of text, one
could expect to see the words mountain, valley, and river appear close to each other
often. The same might be true for mouse, cat, and dog. HAL creates an N by N matrix,
where N is the number of words in its lexicon and each matrix element is the strength of
association between the word represented by the column and row. As the text is analyzed,
a focus word is placed at the beginning of a 10-word reading frame that records which
neighboring words are counted as co-occurring, and the 10-word reading moves
incrementally through a corpus of text. Matrix values are accumulated by weighting the
co-occurrence inversely proportional to the distance from the focus word; closer
neighboring words are thought to reflect more of the focus word's semantics and so are
weighted higher. The semantic similarity between two words is given by the cosine of the
angle between their vectors.
Latent Semantic Analysis (LSA) is one of the most popular techniques of the
corpus-based similarity measure algorithm. It assumes that words are semantically
similar if they appear together in the same context. In LSA, a T × D matrix is constructed
from a text corpus where T is the number of terms in the corpus and D is the number of
documents. With a T × D matrix, a singular value decomposition (SVD) is used to reduce
the number of columns while preserving the similarity structure among rows. Words are
then compared by taking the cosine of the angle between the two vectors formed by any
two rows.
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Generalized Latent Semantic Analysis (GLSA) is a framework for computing
semantically motivated term and document vectors. GLSA extends the applicability of
the idea of the LSA approach, but GLSA focuses on term vectors instead of the dual
document-term representation. GLSA requires a measure of semantic association
between terms and a method of dimensionality reduction. The GLSA approach can
combine any kind of similarity measure on the space of terms with any suitable method
of dimensionality reduction. The traditional term document matrix is used in the last step
to provide the weights in the linear combination of term vectors.
Explicit Semantic Analysis (ESA) is a vectorial representation of text that uses a
document corpus as a knowledge-based measure. It computes the “semantic relatedness”
between two arbitrary texts. The Wikipedia-based technique represents terms (or texts) as
high-dimensional vectors; each vector entry presents the TF-IDF weight between the
term and one Wikipedia article. The semantic relatedness between two terms (or texts) is
expressed by the cosine measure between the corresponding vectors. The name "explicit
semantic analysis" contrasts with latent semantic analysis (LSA) because the use of a
knowledge base makes it possible to assign human-readable labels to the concepts that
make up the vector space.
Cross-Language Explicit Semantic Analysis (CL-ESA) is a multilingual
generalization of ESA. CL-ESA utilizes a document-aligned multilingual reference
collection like Wikipedia to represent a document as a language-independent concept
vector. The relatedness of two documents in different languages is assessed by the cosine
similarity between the corresponding vector representations.
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Pointwise Mutual Information - Information Retrieval (PMI-IR) is a measure of
the similarity of pairs of words. It uses a web-based search engine to calculate
probabilities. The more often two words co-occur near each other on a web page, the
higher is their PMI-IR similarity score. PMI-IR uses Pointwise Mutual Information (PMI)
as follows.
^K>(|, }) =

^(`, n)
=
p(x)p(y)

^(`|n)
=
^(`)

^(n|`)
^(n)

Second-order Co-occurrence Pointwise Mutual Information (SCO-PMI) is a
semantic similarity measure using pointwise mutual information to sort lists of important
neighbor words of the two target words from a large corpus. SOC-PMI can calculate the
similarity between two words that do not co-occur frequently because they co-occur with
the same neighboring words. The method considers the words that are common in both
lists and aggregates their PMI values (from the opposite list) to calculate the relative
semantic similarity.
Normalized Google Distance (NGD) is a semantic similarity measure based on
the number of hits from the Google search engine for a given set of keywords. Keywords
with the same or similar meanings tend to be "close" in units of Google distance, while
words with dissimilar meanings tend to be farther apart.
The Normalized Google Distance between two search terms x and y is as follows:
6$(`, n) =

max{log G(`), log G(n)| − log G(`, n)
logM − min{log G(`), log G(n)}

where M is the total number of web pages searched by Google; f(x) and f(y) are the
number of hits for search terms x and y; and f(x, y) is the number of web pages on which
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both x and y occur. If the two search terms x and y never occur together on the same web
page and they occur on separate web pages, the NGD is infinite. If they always occur on
the same page, their NGD is zero.
Extracting Distributionally-related Words Using Co-occurrences (DISCO) is a
Java-based application that allows the retrieval of the distributional similarity between
arbitrary words and phrases. The Distributional Hypothesis in linguistics is derived from
the semantic theory of language usage. The words that are used and occur in the same
contexts tend to purport similar meanings. Large text collections are statistically analyzed
to get the distributional similarity. When two words are subjected for exact similarity,
DISCO simply retrieves their word vectors from the indexed data and computes the
similarity according to Lin measure. If the most distributionally similar word is required,
DISCO returns the second order word vector for the given word. DISCO has two main
similarity measures: DISCO1 and DISCO2. DISCO1 computes the first order similarity
between two input words based on their collocation sets. DISCO2 computes the second
order similarity between two input words based on their sets of distributionally similar
words.
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Knowledge-Based Similarity Measures
Knowledge-based similarity is a semantic similarity measure that determines the
degree of similarity between words using information derived from semantic networks.
WordNet is the most popular semantic network in the area of measuring the knowledgebased similarity between words. WordNet is a huge lexical database of English words. It
groups English words into sets of synonyms called synsets, provides short definitions and
usage examples, and records a number of relations among these synonym sets or their
members. Synsets are interlinked by means of conceptual-semantic and lexical relations.
Figure 16 shows knowledge-based similarity measures, which can be categorized into
two groups: measures of semantic similarity and measures of semantic relatedness.
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Figure 16. Knowledge-Based Similarity Measures (Gomaa and Fahmy 2013)

Measures of semantic similarity are often based on information regarding “is-a”
relations found in a concept hierarchy. It takes two concepts as input and returns a
numeric score that measures how much they are alike, based on is-a relationships. For
example, common cold and illness are similar in that a common cold is a kind of illness.
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However, there are other relations between concepts such as has-part, is-a-kind-of, is-aspecific-example-of, and is-the-opposite-of that existing measures of similarity cannot
use since they only account for is-a relations (Pedersen, 2005). This suggests that more
general measures of semantic relatedness are needed to take advantage of the increasingly
rich ontologies (particularly in the medical domain) that have a wealth of relations
beyond is-a (Pedersen, 2005).
There are six measures of semantic similarity; three of them are based on
information content and the other three measures use path length.
The res is a Perl module for computing semantic relatedness of word senses that
uses an information content-based measure described by Resnik (1995). The res measure
uses the information content of concepts, computed from their frequency of occurrence in
a large corpus, to determine the semantic relatedness of word senses.
The lin (Lin 1998) and jcn (Jiang and Conrath 1997) measure and augment the
information content of the Least Common Subsumer (LCS) with the sum of the
information content of concepts A and B themselves. The lin measure scales the
information content of the LCS by this sum, while jcn takes the difference of this sum
and the information content of the LCS.
Three similarity measures are based on path lengths between concepts: lch
(Leacock & Chodorow 1998), wup (Wu & Palmer 1994), and path. The lch measure
finds the shortest path between two concepts and scales that value by the maximum path
length in the “is-a” hierarchy in which they occur. The wup measure finds the path length
to the root node from the LCS of the two concepts, which is the most specific concept
they share as an ancestor. This value is scaled by the sum of the path lengths from the
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individual concepts to the root. The measure path is equal to the inverse of the shortest
path length between two concepts.
Furthermore, there are three measures of semantic relatedness. The hso by Hirst
and St-Onge (1998), the lesk by Lesk (1986), and the vector. The hso measure works by
finding lexical chains linking two word senses. There are three classes of relations that
are considered: extra-strong, strong, and medium-strong. The maximum relatedness score
is 16. The lesk measure works by finding overlaps in the terms of the two synsets. The
relatedness score is the sum of the squares of the overlap lengths. The vector measure
creates a co–occurrence matrix for each word used in the WordNet glosses from a given
corpus and then represents each gloss and concept.
In this section, similarity measurement algorithms were reviewed and categorized
according to three approaches: string-based measures, corpus-based measures, and
knowledge-based measures. Generally, patient records and clinical trial subject eligibility
criteria are not written in grammatically perfect sentences. In most cases, they are written
as fragmented sentences or bullet points. Therefore, using corpus-based similarity
measures is not a good idea since this requires a corpus, which is a large collection of
written or spoken text data. Clinical trial subject eligibility criteria include a large number
of medical terms, so cosine similarity from term-based distance measures was selected
for the matching process. Also, knowledge-based measures were combined with termbased distance measures by using UMLS semantic networks for semantic feature
expansion. In this essay, I adopt a hybrid similarity measure, which combine term-based
and knowledge-based distance measures.
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4.4. Research Method
Figure 17 shows the steps for matching patient health records with clinical trial
clusters and individual clinical trials. The first step of this research was to prepare clinical
trial data from ClinicalTrials.gov and patient data from a prior research database. The
second step was pre-processing using lemmatization, tokenization, and stop word
removal. The next step was expanding the feature set with the custom dictionary and
UMLS semantic network. A two-phase matching process was then conducted. Phase I
matched patient information with the clusters that were generated in essay 2. Phase II
matched patient information and clinical trials within the clusters. Also, patient
information was matched with the entire clinical trial data set. Finally, internal and
external evaluations were conducted.
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Figure 17. Steps in Automatic Matching of Patient Record and
Clinical Trial Clusters / Individual Clinical Trials

4.4.1. Data Set
The patient data were acquired from a large community hospital in a major urban
area in the Midwest, where, on average, 150 patients are diagnosed with breast cancer
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each year. The original data set was collected for a prior research study (Gaudioso 2010)
and has structured data such as demographic information as well as unstructured data
such as documents (e.g., pathology, radiology, surgery reports). I collected only
unstructured patient text data such as provider notes, biopsy reports, diagnostic workups,
personal medical histories, physical exam reports, and surgery reports. All the patient
data were de-identified, so the names of the patients were not included. I collected text
data for a total of 148 patients, out of which data for 38 patients was excluded because
there was not sufficient text data for those patients. Therefore, a data set of 110 patients
was used for the matching process.
The database entities in the original study were normalized to secure data
consistency. For the uniqueness of patient level records, the lower level data set was
integrated into the higher level. The hierarchy of the patient data structure is presented in
Figure 18. The lowest level of patient data is “encounter,” which is defined as “An
interaction between a patient and healthcare provider(s) for the purpose of providing
healthcare service(s) or assessing the health status of a patient” by ANSI-accredited
standards developing organization, Health Level Seven International (HL7). The
encounter level records were aggregated to Episode, which is defined as "An important
event or series of events taking place in the course of continuous events” by Farlex
Partner Medical Dictionary (2012). The episode level data was consolidated into case
level. The definition of “case” in the medical field is “An instance of disease with its
attendant circumstances,” according to the Farlex Partner Medical Dictionary (2012).
Finally, all the case records were integrated into the patient level.
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Figure 18. Hierarchy of Patient Data Structure

Figure 19 presents an SQL query statement to integrate a patient record, and
Table 27 shows a sample of an integrated patient record.

Figure 19. SQL Query Statement to Integrate Unique Patient Record

118

Table 27. Sample of Integrated Patient Record

Patient ID

1000001

Original Patient Record
Right breast, partial/simple mastectomy: - Breast tissue with
proliferative fibrocystic changes. - Residual areas of lobular
cancerization - No definite residual DCIS - Previous biopsy site
changes. - Margins free of involvement. -Prognostic factors
performed on previous biopsy CS08-12007: ER +(97%), PR+(85%)
PREOPERATIVE DIAGNOSIS: Ductal carcinoma in situ, right
breast, status post core biopsy, intermediate grade, cribriform type
ER-PR positive. POSTOPERATIVE DIAGNOSIS: Ductal carcinoma
in situ, right breast, status post core biopsy, intermediate grade,
cribriform type ER-PR positive. PROCEDURE: Right mastectomy
with level I axillary node excision. 1. This is a 50-year-old woman,
who has had right mastectomy for recently diagnosed ductal
carcinoma in situ of the right breast that also has features of lobular
cancerization. She is stage pT1N0M0 and I recommend hormonal
therapy with tamoxifen 20 mg daily for 5

Clinical trial data were collected from ClinicalTrials.gov. The search term "breast
cancer" was applied to limit clinical trials to only the breast cancer domain. A total of
1,660 breast cancer clinical trials from January 1, 2010, to January 1, 2012, were
downloaded as a collection of XML format files. A custom parser was used for removing
unnecessary tags, and the clinical trial subject eligibility section was divided based on
two opposite criteria: Inclusion and Exclusion. The basic structured information for
eligibility criteria, gender, and age range was also maintained by including that
information in the data file naming rule.
The clinical trial cluster data came from the second essay. I generated 596 clusters
that had more than single instance and labeled each cluster using the most frequent
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synonym chunk of semantic features. The same cluster data and labels were used for the
matching process in this essay.

4.4.2. Pre-processing
Tokenization and lemmatization were performed for the patient data set with
Stanford CoreNLP. The second step in pre-processing was stop word removal. Fox’s stop
words list with the Apache Lucene framework was applied to sieve out all insignificant
words in the data. Table 28 presents a sample of the pre-processed patient record.

Table 28. Sample of Pre-processed Patient Record

Patient ID

1000001

Pre-processed Patient Text Data
right breast partial simple mastectomy breast tissue proliferative
fibrocystic change residual area lobular cancerization definite residual
dci previous biopsy site change margin free involvement prognostic
factor perform previous biopsy cs08-12007 er 97 pr 85 preoperative
diagnosis ductal carcinoma situ right breast status post core biopsy
intermediate grade cribriform type er pr positive postoperative
diagnosis ductal carcinoma situ right breast status post core biopsy
intermediate grade cribriform type er pr positive procedure Right
mastectomy level axillary node excision 1 50-year old woman right
mastectomy recently diagnose ductal carcinoma situ right breast
feature lobular cancerization stage pt1n0m0 recommend hormonal
therapy tamoxifen 20 mg daily 5

4.4.3. Matching with a Custom Dictionary
First, all trigram combinations from the pre-processed data set were identified;
then each trigram term was matched with the custom dictionary. The three unigram
tokens in the matched trigram were eliminated from the original data set. After all trigram
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matching was completed, all bigram combinations from the modified data set were
derived and matched with the custom dictionary. Table 29 shows trigram matching
results between patient record 1000013 and the custom dictionary.
Table 29. Trigram Matching with the Custom Dictionary

Patient ID

Pre-processed patient record

Trigram Matching with
The Custom Dictionary

successful ultrasound guided core
biopsy highly suspicious palpable
mass 12 30 position right breast ribbon
shaped clip placement pathology grade
iii invasive ductal carcinoma
concordant 2 successful ultrasound
guided vacuum assisted biopsy right
breast 9 00 position s shaped clip
placement pathology grade iii invasive
ductal carcinoma concordant 3 Post
biopsy digital right mammogram show
accurate placement biopsy marking

1000013

clip separate distance 6.4 cm.yes
hematoma
1000013200001430000075000042 1
successful ultrasound guided core
biopsy highly suspicious palpable
mass 12 30 position right breast ribbon
shaped clip placement pathology grade
iii invasive ductal carcinoma
concordant 2 successful ultrasound
guided vacuum assisted biopsy right
breast 9 00 position s shaped clip
placement pathology grade iii invasive
ductal carcinoma

invasive_ductal_carcinoma
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Table 30 shows bigram matching results between patient record 1000013 and the
custom dictionary.
Table 30. Bigram Matching with the Custom Dictionary

Patient ID

Pre-processed patient record

Bigram Matching with
The Custom Dictionary

successful ultrasound guided core
biopsy highly suspicious palpable
mass 12 30 position right breast ribbon
shaped clip placement pathology grade
iii invasive ductal carcinoma
concordant 2 successful ultrasound
guided vacuum assisted biopsy right
breast 9 00 position s shaped clip
placement pathology grade iii invasive
ductal carcinoma concordant 3 Post
biopsy digital right mammogram show
accurate placement biopsy marking

1000013

clip separate distance 6.4 cm.yes
hematoma
1000013200001430000075000042 1
successful ultrasound guided core
biopsy highly suspicious palpable mass
12 30 position right breast ribbon
shaped clip placement pathology grade
iii invasive ductal carcinoma
concordant 2 successful ultrasound
guided vacuum assisted biopsy right
breast 9 00 position s shaped clip
placement pathology grade iii invasive
ductal carcinoma

core_biopsy
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4.4.4. Matching with the UMLS Semantic Network
A patient record is not a wordy document but is a succinct depiction of patient
status. Moreover, the contents in a patient record are written by a healthcare provider and
the target audience includes healthcare experts, so the patient record usually includes
numerous medical terms. For that reason, I expanded the feature set in the patient record
and the clinical trial eligibility section with synonymously related terms from the UMLS
Semantic Network, based on semantic relatedness.
All bigram and trigram terms that matched with the custom dictionary were
processed with the UMLS Semantic Network to find synonyms. Each bigram and trigram
term was queried with the UMLS Semantic Network using a custom query statement.
Table 31 shows the UMLS synonym matching results for each trigram and bigram
term.
Table 31. UMLS Synonym Matching Results for Trigram and Bigram

Patient ID

1000013

Trigrams and Bigram Found
in Custom Dictionary

UMLS Synonym Matching

invasive_ductal_carcinoma

No Match

core_biopsy

Biopsy-action
BX-Biopsy
Biopsy_sampling

4.4.5. Matching patient records with clinical trials within a cluster
There is considerable evidence that information technology could improve the
subject recruitment process in clinical research. Dugas et al. (2009) showed that
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complete, high-quality, and accurate data can significantly enhance the recruitment
process. However, most relevant patient information still remains in an unstructured
format (e.g., clinical notes, clinical assessments). The main objective in this essay is to
find the best matching trials for a patient and to do this efficiently. Thus, the process
starts with matching the patient record with clinical trial information
In this study I selected cosine similarity to compute the matching score between a
patient record and a clinical trial cluster as well as between the patient record and each
clinical trial, because cosine similarity is a measure of similarity between two vectors and
is most commonly used in high-dimensional positive spaces. One of the reasons for the
popularity of cosine similarity is that it is very efficient to evaluate, especially for sparse
vectors, as only the non-zero dimensions need to be considered.
The cluster matching process was a two-step process. First, the matching between
patient records and clinical trial clusters was conducted, and then each trial within the
best matching cluster was also compared with the patient record. In the cluster matching,
I included all clusters, including clusters with one trial. One of the main objectives in
clustering is to reduce the search space for patient and trial matching. Therefore, to
validate the efficiency of clustering, I compared the trial matching results within clusters
with the matching results for the entire trial data set. Also, I set the threshold value for the
best matched cluster as 0.95. All clusters that scored at or above 0.95 were included for
the cluster matching.
Sample results for cluster matching are presented in Table 32. The highest
matching score between patient and cluster is 1 and the lowest score is 0.4666. After all
the best matching clusters for each patient were identified, I compared the patient records
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with the clinical trials within those clusters. Phase I matches the patient records with the
cluster information, while Phase II matches patient records with clinical trials within the
matched clusters. In Phase II matching, two experiments were also conducted. In the first
experiment in Phase II, the matching process was stopped when it found a trial whose
similarity score was more or equal to 0.90. In the second experiment, I compared the
patient record with all the trials in the best matching clusters. I also examined the
matching results with the entire trial data set for the purpose of comparison. Figure 20
presents the matching experiments conducted in this study.

Figure 20. Matching Experiments in Research

In each trial, the subject eligibility criteria were divided into two groups:
“Inclusion” and “Exclusion.” Inclusion criteria are characteristics that the prospective
subjects must have if they are to be included in the study, while exclusion criteria are
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those characteristics that disqualify prospective subjects from inclusion in the study.
Therefore, in this experiment, I excluded the trials whose exclusion criteria matched with
the patient record. For example, the exclusion criteria included terms like “smoking” or
“pregnant” because the study participant should not smoke or should not be pregnant. If
any feature from the exclusion criteria matched with any feature of the patient record,
that match was not included in the final results.
Table 33 shows the results of the trial within cluster matching for a patient. The
highest matching score between the patient and trial within the cluster is 0.8101 and the
lowest is 0.4730.

4.4.6. Matching patient record with entire clinical trial
Additional experiments were performed with each patient record and the entire set
of clinical trials to find the best matches, regardless of clusters. Table 34 shows the
sample results of matching between a patient and trials from the entire pool. The highest
matching score between patient and trial information is 1 and the lowest matching is
0.1708.

Table 32. Sample of Patient and Cluster Matching Result

Patient
ID

Patient_text

1000001

Right breast, partial/simple mastectomy: - Breast
tissue with proliferative fibrocystic changes. Residual areas of lobular cancerization - No
definite residual DCIS - Previous biopsy site
changes. - Margins free of involvement. Prognostic factors performed on previous biopsy
CS08-12007: ER +(97%),
PR+(85%) ,PREOPERATIVE DIAGNOSIS:
Ductal carcinoma in situ, right breast, status post
core biopsy, intermediate grade, cribriform type
ER-PR positive. POSTOPERATIVE DIAGNOSIS:
Ductal carcinoma in situ, right breast, status post
core biopsy, intermediate grade, cribriform type
ER-PR positive. PROCEDURE: Right mastectomy
with level I axillary node excision. ,1. This is a 50year-old woman, who has had right mastectomy for
recently diagnosed ductal carcinoma in situ of the
right breast that also has features of lobular
cancerization. She is stage pT1N0M0 and I
recommend hormonal therapy with tamoxifen 20
mg daily for 5

Cluster_ID

Cluster_label

Cluster
matching
score

Carcinoma, no subtype|Epithelial tumor,
malignant|Carcinoma|Malignant
epithelial tumor|Malignant epithelial
tumour|Epithelial tumour,
Inc(24)_Exc(127)

malignant||Drug preparation|Drug
product|Drug|Medicinal product|General

1

drug type|Pharmaceutical / biologic
product|Medicine|Medication|Drug,
medicament or biological
substance|Drug or medicament
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Table 33. Sample of Patient and Trial within Cluster Matching Result

Best matching Trial within Cluster
Patient_text

1000001

Right breast, partial/simple
mastectomy: - Breast tissue with
proliferative fibrocystic changes. Residual areas of lobular cancerization
- No definite residual DCIS - Previous
biopsy site changes. - Margins free of
involvement. -Prognostic factors
performed on previous biopsy CS0812007: ER +(97%),
PR+(85%) ,PREOPERATIVE
DIAGNOSIS: Ductal carcinoma in
situ, right breast, status post core
biopsy, intermediate grade, cribriform
type ER-PR positive.
POSTOPERATIVE DIAGNOSIS:
Ductal carcinoma in situ, right breast,
status post core biopsy, intermediate
grade, cribriform type ER-PR positive.
PROCEDURE: Right mastectomy
with level I axillary node excision. ,1.

CT_ID

CT_text

CT
matching
score

NCT01183663

Inclusion Criteria:
1. Patients with advanced or
metastatic cancer that is refractory to standard therapy,
has relapsed after standard therapy, or for which there is no
standard therapy
available.
2. Patients must
be >/= 3 weeks beyond treatment with a cytotoxic
chemotherapy regimen,
therapeutic radiation, or
major surgery. After targeted or biologic therapy there
should be 5 half-lives or three weeks, whichever is shorter.
Patients may have
received palliative localized
radiation immediately before or during treatment,
providing radiation is not delivered only to the site of
disease being treated under
this protocol.
3.
Eastern Cooperative Oncology Group (ECOG) performance
status </= 2
4. Patients must have normal organ and
marrow function, defined as absolute neutrophil
count >/= 1,000/mL; platelets >/=50,000/mL (unless these
abnormalities are due to
bone marrow involvement);
creatinine clearance >/= 50 ml/min by Cockcroft-Gault
formula; total bilirubin </= 2.0; and alanine
aminotransferase (ALT)/ serum glutamic
pyruvic
transaminase(SGPT) </= 5 X ULN (unless patient has liver
metastases).
5. All study participants must be
registered into the mandatory RevAssist® program, and

0.6410
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Patient
ID

This is a 50-year-old woman, who has
had right mastectomy for recently
diagnosed ductal carcinoma in situ of
the right breast that also has features of
lobular cancerization. She is stage
pT1N0M0 and I recommend hormonal
therapy with tamoxifen 20 mg daily for
5
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be willing and able to comply with the requirements of
RevAssist®.
6. Females of childbearing potential
(FCBP) must have a negative serum or urine
pregnancy test with a sensitivity of at least 50 mIU/mL
within 10 - 14 days prior to
and again within 24
hours of prescribing lenalidomide (prescriptions must be
filled
within 7 days) and must either commit to
continued abstinence from intercourse or
begin
TWO acceptable methods of birth control, one highly
effective method and one
additional effective
method AT THE SAME TIME, at least 28 days before she
starts
taking lenalidomide. FCBP must also agree to
ongoing pregnancy testing. Men must
agree to use a
latex condom during sexual contact with a FCBP even if
they have had a
successful vasectomy.
7.
Patients must be able to understand and be willing to sign a
written informed consent
document.
8. Must
be >/= 18 years of age.
Exclusion Criteria:
1.
Any serious medical condition, laboratory abnormality, or
psychiatric illness that
would prevent the subject
from signing the informed consent form.
2.
Uncontrolled intercurrent illness, including, but not limited
to, uncontrolled
infection, uncontrolled asthma,
need for hemodialysis, need for ventilatory support.
3. Pregnant or breast feeding females. (Lactating females
must agree not to breast feed
while taking
lenalidomide).
4. Use of any other experimental drug
or therapy within 21 days of baseline.
5. Known
hypersensitivity to thalidomide.
6. History of
hypersensitivity to any component of the formulation.
7. The development of erythema nodosum, if characterized
by a desquamating rash while
taking thalidomide or

similar drugs.
8. Patients unwilling or unable to sign
informed consent document.
9. Uncontrolled
systemic vascular hypertension (Systolic blood pressure
>140 mmHg,
diastolic blood pressure > 90 mmHg
on medication) for patients treated in the
bevacizumab or sorafenib arms.
10. Patients with
active deep venous thrombosis or pulmonary embolism or
patients
receiving anti-coagulation.
11.
Patients with clinically significant cardiovascular disease:
History of
cerebro-vascular accident (CVA) within 6
months; Myocardial infarction or unstable
angina
within 6 months; Unstable angina pectoris.
12.
Uncontrolled intercurrent illness, including, but not limited
to, ongoing or active
infection requiring parenteral
antibiotics on Day 1.
13. Major surgical procedure,
open biopsy or significant traumatic injury within 28 days
prior to Day 0 of protocol treatment.
14. Patients that
are taking CYP3A4 inducers and/or inhibitors, being
considered for the
temsirolimus arm: If a patient has
a history of taking CYP3A4 inducers and/or
inhibitors prior to enrollment on the temsirolimus arm, it is
strongly recommended
that the patient stops the
drug and waits at least 5 half-lives of said drug before
initiating therapy on the temsirolimus arm.
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Table 34. Sample of Patient and Trial among Entire Trial set Matching Result

Best matching Trial among Entire Trial set
Patient_text

1000001

Right breast, partial/simple
mastectomy: - Breast tissue with
proliferative fibrocystic changes. Residual areas of lobular cancerization
- No definite residual DCIS - Previous
biopsy site changes. - Margins free of
involvement. -Prognostic factors
performed on previous biopsy CS0812007: ER +(97%),
PR+(85%) ,PREOPERATIVE
DIAGNOSIS: Ductal carcinoma in
situ, right breast, status post core
biopsy, intermediate grade, cribriform
type ER-PR positive.
POSTOPERATIVE DIAGNOSIS:
Ductal carcinoma in situ, right breast,
status post core biopsy, intermediate
grade, cribriform type ER-PR positive.
PROCEDURE: Right mastectomy
with level I axillary node excision. ,1.
This is a 50-year-old woman, who has
had right mastectomy for recently

CT_ID

CT_text

Inclusion Criteria:
Any participant 18 years or
older and are MR safe.
Exclusion Criteria:
That study participants will be excluded if they have
NCT01757730 any unapproved metal in their
bodies, and that
the volunteers are pregnant or possible of becoming
pregnant. Also if
the participants are
claustrophobic.

CT
matching
score

0.9813
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Patient
ID

diagnosed ductal carcinoma in situ of
the right breast that also has features of
lobular cancerization. She is stage
pT1N0M0 and I recommend hormonal
therapy with tamoxifen 20 mg daily for
5
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4.5. Results
When I included single-instance and two-instance clusters in the experiment, the
best match score between patient and cluster was always 1. Also, all the patients matched
with multiple best clusters with score 1, and the number of best matched clusters ranged
from 2 to 128. Table 35 shows the score results for patient and cluster matching. All the
patients had at least one best match with a cluster, and all of the best matches had a score
of 1. Thus, the upper bound and lower bound scores were both 1.

Table 35. Matching Results for Patient and Clinical Trial Clusters

Highest Best Matching Score

1

Lowest Best Matching Score

1

Number of Multiple Matches

110

Range of Multiple Matches

2 to 128

The match results between patient and individual clinical trials within the clusters
were obtained through two different experiments. In the first experiment, the matching
process was stopped when it found a trial whose match score was more than 0.90; the
results from that experiment are presented in Table 36.
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Table 36. Matching Results for Patient and Trial within Best Matched Cluster
(Stop at First Match)

Highest Best Matching Score

0.9862

Lowest Best Matching Score

0. 9289

Average Best Matching Score

0.9632

In the second experiment, I compared the patient record with all the trials in the
best clusters. The results from the second approach are presented in Table 37. There are
several trial studies that scored 1 because the description of eligibility criteria for those
trials was extremely short. The cosine similarity measure only considers orientation, not
magnitude, so very short documents could have raised the level of noise in the
experiment. To address this shortcoming, all the matches that scored 1 were removed
from the results.

Table 37. Matching Results for Patient and Trial within Best Matched Cluster (All Trials)

Highest Best Matching Score

0.9931

Lowest Best Matching Score

0.9493

Average Best Matching Score

0.9845
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The matching results between patient and the entire trial set are also presented in
Table 38. This matching took around seven times longer than the one involving patient
and all trials in the best clusters. Computationally, it incurred higher costs but produced
similar results as those from patient and trial within the best matched cluster. Table 38
shows the match results between patient and single clinical trial in the entire trial set.

Table 38 Matching Results between Patient and Entire Trial

Highest Best Matching Score

0.9931

Lowest Best Matching Score

0.9493

Average Best Matching Score

0.9845

Number of Multiple Matches

22

Range of Multiple Matches

2

The efficiency of the matching process was evaluated by measuring the matching
algorithm computing time. The main objective of clustering trials in the second essay was
to reduce the search space and lower the computational costs for finding the best trial for
a patient. To evaluate the efficiency of the clustering approach, I investigated the
computing time for the three matching experiments. The system specification for this
research is presented in Table 39.
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Table 39. Research System Specification

OS Name

Microsoft Windows Server 2008 R2 Standard,
64 bit

OS Version

6.1.7601 Service Pack 1 Build 7601

Processor

Intel(R) Xeon(R) CPU E5440 @ 2.83GHz, 2826
Mhz, 1 Core(s), 1 Logical Processor(s)

BIOS Version/Date

American Megatrends Inc. 080002, 5/5/2008
SMBIOS Version 2.3

Total Physical Memory

12.0 GB

Available Physical
Memory

9.12 GB

Total Virtual Memory

24.0 GB

Available Virtual
Memory

18.0 GB

Page File Space

12.0 GB

Disk Size

270.99 GB (290,977,505,280 bytes)

Program Language

java version "1.6.0_45"

Integrated Development
Environment

Eclipse IDE for Java Developers
Version: Juno Service Release 2
Build id: 20130225-0426

Database

MySQL 5.5.30
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Table 40 shows the computing times for the matching process of patient and the
first matched trial within the best matched cluster.

Table 40 Computing Time for the Matching Process of Patient and
Trial within Best Matched Clusters (Stop at First Match)

Longest Computing Time

0.3397 sec

Shortest Computing Time

0.0528 sec

Average Computing Time

0.0867 sec

Table 41 shows the computing time for the matching process of patient and all
trials within the best matched clusters.

Table 41 Computing Time for the Matching Process of Patient and
Trial within Best Matched Clusters (All trial)

Longest Running Time

0.8298 sec

Shortest Running Time

0.1246 sec

Average Running Time

0.3356 sec

Table 42 shows the computing time for the matching process of patient and the
entire trial set.
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Table 42 Computing Time for the Matching Process of Patient and Entire Trial Set

Longest Running Time

3.531461 sec

Shortest Running Time

2.070947 sec

Average Running Time

2.2516 sec

In order to analyze the differences among three group means and variation among
and between groups, I conducted the analysis of variance (ANOVA) test. Table 43 shows
a summary of the three experimental groups, and Table 44 presents the results of the
ANOVA test.

Table 43. Summary of Three Experiment Groups for Patient and Trial Matching

Groups

Counts

Sum

Average

Variance

Patient and Trial within
Best Matched Clusters
(Stop at First Match)

110

9.6327

0.0867

0.0036

Patient and Trial within
Best Matched Clusters
(All trials)

110

37.5165

0.3379

0.0238

Patient and Entire Trial Set

110

250.3816

2.2556

0.04488

Table 44 shows that the p-value is less than 0.05, indicating that the mean values
of computing times for the three experimental groups were significantly different.
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Table 44. Results of ANOVA Test for Three Experiment Groups

Source of
Variation

SS

df

MS

F

p-value

F crit

Between
Groups

312.4595

2

156.2297

6477.9563

0.00

3.0230

Within
Groups

7.95865

330

0.02411

Total

320.4182

332

The mean differences among the three groups were statistically different, and it
can be interpreted that the clustering approach in the patient and clinical trial matching
can significantly expedite the clinical trial subject recruitment process.
A two-tail pairwise t-test was conducted to find differences among the groups.
Table 45 shows results of pairwise t-test. All the p-values were less than 0.5, and
statistically significant differences existed among the three groups.
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Table 45. Results of Pairwise t-test (Two tail)

Groups

Pairwise t-test (two tail)

Patient and Trial within
Best Matched Clusters
(Stop at First Match)

0.0001

Patient and Trial within
Best Matched Clusters
(All trials)

0.0001

Patient and Entire Trial Set

0.0001

The quality of the matching was evaluated in this study using psycholinguistic
evaluation. This evaluation approach is usually used for assessing the quality of semantic
similarity measures. The psycholinguistic approach compares the computational
approaches with human judgements. The correlation between the computational approach
and human assessment is used as an evaluation measure to judge the quality of the
similarity measure. The matching results were evaluated internally by researchers
involved in the study and were then reviewed by an external medical expert who was a
medical doctor as well as a PhD in management science. The internal researchers
preliminarily tested the quality of the matching results and then the external medical
expert assessed the quality of a sample of five final matching results. Table 46 shows the
results of expert evaluation. The expert review reported one ‘Very Good’ and four
‘Average’ ratings. The expert provided comments as part of the evaluation. The
comments on average ratings explained why he didn’t mark those matches ‘Very Good’
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or ‘Good’. All the ‘Average’ rated matches were because of significant missing
information in patient data that is required for a good match. For example, one of the
expert’s comments was that “Match on Confirmed diagnosis and ER, PR, Her status, and
ax LNs. However, we are missing data on menopausal status and performance status…”
The results from three experiments were discussed and showed the proposed two
step matching results provided statistically improved performance. The matching results
could be used for patient recruitment, estimation of clinical trial feasibility, and helping
terminal disease patients.

Table 46. Results of Expert Evaluation for 5 Sample Matches

Value in Likert Scale

Count

Very Good

1

Good

-

Average

4

Poor

-

Very Poor

-

Total

5
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4.6. Discussion
To the best of our knowledge, no attempt has so far been made to build an entire
automatic matching process for clinical trial and patient information using state-of-the-art
NLP and text mining algorithms. Also, this research is the first study that adopts the
semantic-based feature expansion technique, which can improve clinical trial text
analysis performance. Based on prior studies, the n-gram feature induction approach
yielded more accurate outcomes for machine learning-based text analysis. I tried to
capture the n-gram medical terms using the domain-specific custom dictionary, which, in
clinical trial research, is the first attempt at applying the n-gram feature induction
approach. Previous research on clinical trials failed to grasp the characteristics of the two
opposite criteria in the eligibility section. In this research, we divided the subject
eligibility section into “Inclusion Criteria” and “Exclusion Criteria” section to reflect the
impact of each set of criteria precisely. Finally, we matched patient data with clinical trial
clusters, under which similar alternative clinical trials were grouped. The results of the
matching reduced healthcare practitioners’ search space for clinical trials and
significantly enhanced their patients’ participation opportunity in trials.
I have presented a feasibility study for an NLP and text mining-based approach to
matching patient records with clinical trials. Using a real-world patient data set, we
described various framework and algorithms to address issues in the automatic patient
recruitment process.
This study contributes to both research and practice. The study contributes to
research by proposing a framework and providing algorithms based on semantic feature
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expansion. Moreover, the algorithms and framework from this research could be used for
different types of diseases and patient groups.
This study is not without limitations. In its current scope, it has limited
generalizability. I only focused on the breast cancer domain with a limited set of patient
records. Furthermore, this study adopted the cosine similarity measure in the matching
process. However, there are several similarity measures that have been used in other
research domains, such as information retrieval and computer science. Emerging
similarity measure algorithms could be evaluated in the future. Moreover, by the nature
of cosine similarity, semantics of documents were not considered in this research.
Negation expression in clinical trial and patient text could not be captured.
There are several ways in which future research could strengthen the results of
this study. As a further extension of our work, future researchers could conduct a field
study involving a real hospital environment. Future studies could investigate the proposed
model in the context of different types of disease. Semantic analysis could also be
included in future research.
About 85% of people with cancer were either unaware or unsure that participation
in clinical trials was an option, although about 75% of them said they would have been
willing to enroll had they known it was possible. However, the clinical trial subject
matching process is labor intensive and error prone. Our research would streamline the
entire matching process and provide effective support to terminal disease patients.
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CHAPTER 5
Conclusion and Future Directions

“It is a very sad thing that nowadays there is so little useless information.”
Oscar Wilde

5.1. Introduction
It has been extensively recognized that recruitment of an adequate number of
participants is essential for success of a clinical trial. Several studies have found that low
participation in clinical trials is a significant issue resulting in inadequate statistical
analyses of outcomes, premature closure of trials, longer trial duration, and higher costs
of medical treatment.
In the field of oncology, fewer than 3% of potentially eligible patients enroll in
clinical trials, and patient enrollment for clinical trials is as low as 2% of patient
recruitment goals. Furthermore, more than 75% of participants are not even aware that
trials exist, even though surveys have shown that a majority of people would be open to
participating in these studies if they knew about them.
Extensive literature has been written about barriers to clinical trial participation,
and one of the salient barriers for potential participation is participation of physicians.
The participation of physicians is necessary to the success of clinical trial subject
recruitment because they serve a critical role in helping their patients access trials.
However, they do not have enough time to identify eligible study subjects efficiently, or
they simply forget to offer and enroll patients in possible trials.

144

Therefore, it is necessary to develop new technologies and automatic tools that
can process large text data into useful information and knowledge intelligently. NLP and
text mining is a technique that can combine traditional data analysis methods with
complex algorithms to deal with large amounts of text data. Additionally, text mining is a
complex process that can extract the unknown and valuable modes or rules from mass
data.
This three-essay dissertation attempts to contribute a solution to clinical trial
subject recruitment problem. This study aims to provide an automatic matching
framework for patient text information and clinical trial subject eligibility description. To
achieve the main objective, I created a domain-specific custom dictionary as a lexical
resource in essay 1, generated clinical trial clusters for the breast cancer domain in essay
2, and proposed a two-step automatic matching process in essay3.
One of the most time-consuming and high labor cost tasks in text mining research
is the creation, compilation, and customization of the necessary lexicons. The first essay
attempted to build a domain-specific lexicon focusing on breast cancer and showed the
semi-automated dictionary building process. The evaluations for the breast cancer
domain-specific dictionary shows that even though the coverage of a domain-specific
dictionary is slightly less than the UMLS Metahthesaurus, the efficiency is more than 30fold higher than UMLS resources
This second essay grouped and summarized clinical trial subject eligibility using
the clustering approach. This essay also showed the framework for clustering clinical trial
and labeling process. The findings from the second essay suggest that the clustering
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approach could help practicing physicians reduce the search space of potential clinical
trials.
The last essay proposed an entire automatic matching process for clinical trial and
patient information using state-of-the-art NLP and text mining algorithms. This study
contributes to both research and practice. The study contributes to research by providing
algorithms and a framework based on semantic feature expansion. Moreover, the findings
in this research, such as algorithms and the framework on which they are based, could be
used for different types of diseases and patient groups.

5.2. Limitations
No claim is made as to the completeness of this research study. For the first essay,
the coverage rate of the custom dictionary is relatively low because the data set included
not only noun but also verb, adverb, and adjective words. Second, the custom dictionary
included limited online sources. Thus, if a more comprehensive resource is included in
future research, it will result in better performance.
The second essay focused only on the context of the breast cancer domain, which
may represent lack of generalizability. While agglomerative hierarchical clustering with
cosine distance was adopted to cluster clinical trials, other clustering algorithms and
distance measures need to be compared.
The scope of the last essay has limited generalizability. I focused only on the
breast cancer domain with limited patient records. The last essay also adopts cosine
similarity to measure in the matching process. However, there are several other similarity
measures that can be used for other research domains, such as information retrieval and
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computer science. Emerging similarity measure algorithms should be evaluated.
Semantic analysis of documents were not considered in this research. Negation
expressions in data were not captured.

5.3. Future Directions
As described in the conclusion section for each individual essay, there is always
room for enhancement and extension of the algorithms used in these essays. Future
research for the first essay could be evaluation with only a noun word data set, which
could increase the coverage rate of custom dictionary. The custom dictionary included
limited online sources. Therefore, if a more comprehensive resource is included in future
research, it will result in better performance.
There are several ways in which future research could strengthen the results of the
second essay. First, future studies could investigate the proposed clustering framework in
the context of different kinds of diseases to extend generalizability. Second, different
approaches for clustering and document similarity metrics could be used. For example,
Latent Dirichlet allocation (LDA), latent semantic indexing, independent component
analysis, probabilistic latent semantic indexing, non-negative matrix factorization, and
Gamma-Poisson distribution techniques are used in bioinformatics research. These new
techniques could be applied in future research.
As a further extension of the third essay, researchers could conduct a field study
involving a real hospital environment. Also, future studies could investigate the proposed
model in the context of different types of diseases. To capture negation expressions,
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semantic analysis could be included in future direction. Our research would streamline
the entire matching process and provide effective support to terminal disease patients.
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APPENDIX: 5 Sample Matching Results between Patient and Clinical Trials (Essay III)

Patient
ID

1000001

CT_text

Right breast, partial/simple mastectomy: Breast tissue with proliferative fibrocystic
changes. - Residual areas of lobular
cancerization - No definite residual DCIS Previous biopsy site changes. - Margins free
of involvement. -Prognostic factors
performed on previous biopsy CS08-12007:
ER +(97%), PR+(85%) ,PREOPERATIVE
DIAGNOSIS: Ductal carcinoma in situ, right
breast, status post core biopsy, intermediate
grade, cribriform type ER-PR positive.
POSTOPERATIVE DIAGNOSIS: Ductal
carcinoma in situ, right breast, status post
core biopsy, intermediate grade, cribriform
type ER-PR positive. PROCEDURE: Right
mastectomy with level I axillary node
excision. ,1. This is a 00-year-old woman, who
has had right mastectomy for recently
diagnosed ductal carcinoma in situ of the right
breast that also has features of lobular
cancerization. She is stage pT1N0M0 and I
recommend hormonal therapy with
tamoxifen 20 mg daily for 5

Inclusion Criteria:
1. Pathologically
confirmed ductal carcinoma in situ of the breast
or early invasive
breast cancer defined as
pathologic stage Tis, T1, or T2, N0, N1mic, or N1a
(pathologic staging of the axilla is required for all
patients with invasive disease
but is not
2.
required for patients with DCIS only).
Treatment with breast conserving surgery.
3. Final surgical margins must be negative,
defined as no evidence for ductal carcinoma
in situ or invasive breast cancer touching the
inked surgical margin. If the invasive
or in
situ breast cancer approaches within less than 1
mm of the final surgical
margin, then a
reexcision is strongly encouraged. Lobular
carcinoma in situ at the
final surgical
margin will be disregarded.
4. Age 40 years
or older. This age cutoff is justified because
breast cancers in women
under the age of
40 are known to have a significantly higher risk of
IBTR presumably
due to underlying
biologic differences.
5. Female sex.
6.
Attending radiation oncologist declares intention
to treat the whole breast only and
that a
third radiation field to treat regional lymph nodes
is not planned (radiation
of the
undissected level I/II axilla with high tangents is
allowed).
7. If the patient has a history of a
prior non-breast cancer, all treatment for this
cancer must have been completed prior to study
registration and the patient must have
no
evidence of disease for this prior non-breast

Matched
Terms

Expanded
Matched
Terms

Matching
evaluation

ductal
carcinoma in
situ
right breast
T1
level I/II axilla
DCIS
ductal
carcinoma

Duct_adeno
carcinoma
Duct_carcin
oma
Duct_cell_ca
rcinoma
Axillary_foss
a
Axilla_struct
ure
Axilla
Armpit
Structure_of
_axillary_fos
sa
Axillary_regi
on Axillary
Axillary_regi
on_structur
e

Very Good

Comments
(Optional)
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Patient_text

2000024

radotherapy
edema in the
ipsilateral
arm

Radiation_t
herapy
Plesiotherap
y_radiation
Therapeutic
_radiology
Radiation_o
ncology
Oedema
Dropsy
Hydrops
Edematous
Interstitial_e
dema
Interstitial_o
edema

Average

patient has
History of
rather than
experienci
ng edema Questionab
le imaging
findings
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Subtle nodularity in the central subareolar
region of the left breastSubtle nodularity in
the central subareolar region of the left breast
is identified as mildly prominent ductal
elements. There is no suspicious finding
within the left breast. 2. Post lumpectomy
change on the right with an interval change in
the mammographic appearance of the right
breast with an 8 mm poorly defined zone of
nodularity seen in the 12 o'clock position
within the right breast with accompanying
calcifications. Treated with lumpectomy
followed by radiotherapy. Ultrasound only
questionably demonstrates a subtle zone of
altered echotexture in this region. A discrete
palpable lump is not identified on physical

cancer.
8. Patients must be enrolled on the
trial within 12 weeks of the later of two dates:
the
final breast conserving surgical
procedure or administration of the last cycle of
cytotoxic chemotherapy.
Exclusion Criteria:
1. Pathologic or clinical evidence for a stage T3 or
T4 breast cancer.
2. Pathologic evidence for
involvement of 4 or more axillary lymph nodes,
or imaging
evidence of involvement of
infraclavicular, supraclavicular, or internal
mammary
lymph nodes.
3. Clinical
or pathologic evidence for distant metastases.
4. Any prior diagnosis of invasive or ductal
carcinoma in situ breast cancer in either
breast.
5. Current diagnosis of bilateral
breast cancer.
6. History of therapeutic
irradiation to the breast, lower neck,
mediastinum or other
area in which there
could potentially be overlap with the affected
breast.
7. Patients not fluent in English or
Spanish. (The Informed Consent will be available
in
these two languages)
8. Patient is
pregnant.
Inclusion Criteria:
1. Women with a
histological diagnosis of breast cancer
experiencing edema in the
ipsilateral arm
such that there is a minimum 10% and maximum
40% increase in arm
volume over the
unaffected arm (mild to moderate lymphedema).
2. Patients must have completed all primary and
adjuvant treatments (surgery,
chemotherapy, radiotherapy) prior to
randomization.
3. Patients must have their
own fitted compression garment for daytime
maintenance.
4. No past or current use of a
night-time compression system for maintenance.
Those
patients who have trialed a nighttime compression system in the past year must
observe a six-month washout period before

examination. History of edema in the
ipsilateral arm SCREENING TO DIAGNOSTIC
MAMMOGRAPHY AND BILATERAL BREAST
ULTRASOUND: The patient presented for
screening mammography. The breasts were
imaged in the craniocaudal and MLO
projections. Review of these images
demonstrated an interval change with the
appearance of a subtle zone of asymmetric
density within the 12 o'clock position within
the right breast with current.
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Radical mastectomy : - Breast tissue with
proliferative fibrocystic changes. - Residual
areas of lobular cancerization - Positive
axillary lymph nodes. - Margins free of
involvement. -Prognostic factors performed
on previous biopsy CS08-12007: ER(-) /
PR(-), PREOPERATIVE DIAGNOSIS: Ductal
carcinoma in situ, right breast, status post
core biopsy, intermediate grade, cribriform
type ER-PR positive. POSTOPERATIVE
DIAGNOSIS: Ductal carcinoma in situ, right
breast, status post core biopsy, intermediate
grade, cribriform type ER-PR positive.
PROCEDURE: Right mastectomy. This is a 00year-old woman, who has had right
mastectomy for recently diagnosed ductal
carcinoma in situ of the right breast that also
has features of lobular cancerization.

entering the trial.
Exclusion Criteria:
1.
Clinical or radiological evidence of active disease,
either local or metastatic.
2. History of
contralateral breast cancer and axillary surgery.
3. Serious non-malignant disease, such as renal
or cardiac failure, which would preclude
daily treatment and follow-up.
4. Patients
for whom compression is contraindicated.
5. Psychiatric or addictive disorders which
preclude obtaining informed consent or
adherence to the protocol.
6. Unable to
comply with the protocol, measurement and
follow-up schedule.
Inclusion Criteria:
1. Patient must accept
the modified radical mastectomy
2.
Patients with histologically confirmed ER(-) PR(-)
and HER-2(-)
3. Positive axillary lymph
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35 years or Ⅲ
grade or intravascular
cancer embolus.
4. Age between 18 years
to 65 years
5. Able to give informed
consent
6. Patients with an Eastern
Cooperative Oncology Group (ECOG)
performance score of 0 or
1.
7. Not
pregnant, and on appropriate birth control if of
child-bearing potential.
8. Adequate bone
marrow reserve with ANC > 1000 and platelets >
100,000.
9. Adequate renal function with
serum creatinine < 2.0.
10. Adequate
hepatic reserve with serum bilirubin < 2.0,
AST/ALT < 2X the upper limit of
normal,
and alkaline phosphatase < 5X the upper limit of
normal. Serum bilirubin >
2.0 is
acceptable in the setting of known Gilbert's
syndrome.
11. No active major medical or
psychosocial problems that could be complicated
by study
participation.
Exclusion
Criteria:
1. received neo-adjuvant therapy
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Follow-up with surgical consultation:
Postoperative changes and postradiation
changes left breast. No ,Invasive, moderately
differentiated, ductal carcinoma, mBR Grade II
Negative for lymphovascular space invasion. Microcalcification within tumor. ,Infiltrating
lobular carcinoma, mBR Grade I, 1 cm, in a
random section from the lower outer
quadrant (prognostic factors pending),
located approximately 2 cm from the recent
biopsy site. 2.Microscopic focus of residual
infiltrating duct carcinoma, mBR Grade II, 0.1
cm, adjacent to biopsy cavity (previous
stereotactic biopsy, CS-08-10468, showed 0.8
cm tumor). Right axillary lymph nodes
metastasis. - Prognostic factors performed on
previous biopsy ER 100%, PR 92%, Her-2/neu
2+ (not amplified by SISH). 3.Biopsy-related
changes with patchy adjacent atypical duct
hyperplasia and fibrocystic change with
associated microcalcifications. 4. One benign
intramammary lymph node. 5. Skin and nipple
negative for malignancy. 6. Margins of
resection negative for atypia and ma
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2. Cardiac dysfunction documented by an
ejection fraction less than the lower limit of
the facility normal by multi-gated acquisition
(MUGA) scan, or 45% by echocardiogram.
-The rate of Disease recurrence
3.
Uncontrolled medical problems.
4.
Evidence of active acute or chronic infection.
5. Pregnant or breast feeding.
6. Hepatic,
renal, or bone marrow dysfunction as detailed
above.
Inclusion Criteria:
1. The participant has
histopathologically-confirmed primary breast
cancer in Japanese.
2. The participant is
aged 20 years or older when informed consent is
obtained
3. The participant has estrogen
receptor (ER)-positive tumor cells and/or
progesterone
receptor (PgR)-positive
primary tumor. And HER-2 is negative.
4.
The participant has breast cancer in the clinical
stages of T1-T3, N-any and M0 by
TNM
classification (the seventh edition, proposed by
UICC in 2009). (No distant
metastasis to
lung, liver and bone should be confirmed on the
image-based diagnosis
at study
enrollment. The image taken within 12 weeks
prior to study enrollment is
also available
for the diagnosis.) The number of axillary lymph
node metastasis is
not limited.
5.
Any operative procedure for breast cancer is
acceptable. In principle, after
breastconserving surgery, the participant will receive
postoperative radiation to
the conserving
breast.
6. Neoadjuvant chemotherapy and
adjuvant chemotherapy prior to study enrollment
are
acceptable. (It is advisable the same
kind of chemotherapy is performed at each
site.)
7. The participant has a history of
regular menstrual periods within 12 weeks prior
to
study enrollment, or the participant has
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Operative_p
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FSH of less than 40 mIU/mL and E2 of 10
pg/mL or more measured within 12 weeks prior
to study enrollment. The participant
has
not had a chemical menopause (i.e., FSH of less
than 40 mIU/mL and E2 of 10 pg/mL
or
more) within 12 weeks after completing adjuvant
chemotherapy.
8. The participant is in a
condition to receive study drug and Tamoxifen
(TAM) within 12
weeks after surgery or
after adjuvant chemotherapy prior to study
enrollment.
Adjuvant chemotherapy prior
to study is required to have been completed at
the time
of study enrollment.
9. The
participant has ECOG performance status of
grades 0 or 1 at the time of study
enrollment.
10. The participant meets the
following criteria of hepatic, renal and bone
marrow
functions on the laboratory test
results at screening:
- Hepatic function:
AST (GOT) ≤ 3.0 times the upper limit of normal
(ULN) ALT
(GPT) ≤ 3.0 times the ULN
- Renal function: serum creatinine level < 1.5
times the ULN
- Bone marrow function :
white blood cell count ≥ 3,000/mm3 platelet
count ≥
100,000/μL hemoglobin ≥
10.0g/dL
11. The participant agrees to use a
non-hormonal method of contraception through
the
study period.
Exclusion Criteria:
1. The participant has received neoadjuvant or
adjuvant hormonal therapy for the latest
breast cancer surgery.
2. The participant
has received bilateral oophorectomy and
bilateral ovarian
irradiation.
3. The
participant has inflammatory breast cancer or
bilateral breast cancer.
4. The participant
has non-invasive ductal carcinoma.
5. The
participant has multiple primary cancers, or a
history of carcinoma in other
organs.
6. The participant is pregnant or breast-feeding.
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,Document Type: Surg Path Final Report
Document Date: 2010 Document Status: Auth
(Verified) Performed by/Author: XXXX RT on
2010 Verified By: XXXX MD on 2010
Encounter info: 0000000000,, COL,
Outpatient, 2010 - 2010 * Final Report *
Specimen: (Verified) A U/S core bx left breast
14g B U/S core bx left breast 14g C U/S SUROS
left breast Clinical Information: (Verified) A)
U/S core biopsy left breast, 14g, location ?
1:30 lateral. Size 0.8 cm. Left breast mass.
Rad diff dx: Favor invasive CA. B) U/S core
biopsy left breast, 14g, location ? 1:30 medial.
Size 1.1 cm. Left breast mass. Rad diff dx:
Invasive CA strongly favored. C) U/S SUROS
left breast, 9g vacuum assisted. Location ?
3:00, size 6 mm. Note is made that the patient
has undergone a prior right-sided
lumpectomy. in 1999 Left breast mass. Rad
diff dx: Favor invasive CA vs FCC with fibrosis.
Post radiation changes left breast Invasive
ductal carcinoma in situ with lobular features.
Gross Description: (Verified) Specimen A:
Specimen received fresh and placed in
formalin (on 2010

7. The participant has a history of hypersensitivity
to synthetic LH-RH, LH-RH
derivative,
TAM, TAM analogue (antiestrogen) or any
component of the study drug.
8. The
participant has a history of, or has been
diagnosed with thromboembolism
including myocardial infarction, cerebral
infarction, venous thrombosis, and
pulmonary embolism, or cardiac failure.
9.
Patients whose QTcF interval exceeded 460 msec
on the 12-lead electrocardiogram at
screening.
DISEASE CHARACTERISTICS:
- Female
patients newly diagnosed with breast carcinoma
including ductal carcinoma in
situ (DCIS)
- Stage 0-IIIA disease
- Status postlumpectomy, -quadrantectomy, or -mastectomy
- Plan to receive adjuvant radiation to the whole
breast or chest wall and/or regional
lymph
nodes
- No sites that cannot send
blood/urine specimens to Wake Forest by
overnight (next
day) express shipping
PATIENT CHARACTERISTICS:
- *This
stratum is closed as of April 25, 2012.
- No
patients who do not understand English and are
unable to complete form with
assistance
PRIOR CONCURRENT THERAPY:
- Total
dose > 40 Gy, dose per fraction > 1.8 - 2.0 Gy, use
of 2D, 3D-conformal, or
intensitymodulated radiation therapy (IMRT) treatment
techniques allowed; a daily
fraction of 2.7
Gy to the whole breast is suggested for
hypofractionated regimens
- Concurrent
and sequential boost techniques are allowed for
both standard and
hypofractionated
regimens
- Adjuvant hormonal therapy will
be allowed prior to, during, and/or after
radiotherapy
(RT) at the discretion of a
medical oncologist
- Targeted therapies,

such as Herceptin, will be allowed prior to,
during, and/or after
RT at the discretion of
the medical oncologist
- No prior radiation
to the involved breast or chest wall
- No
concurrent chemotherapy
- No patients
who underwent breast reconstruction following
mastectomy
- Placement of tissue
expanders and implants are not allowed
No patients who have undergone MammoSite®
or any other form of brachytherapy as well
as those who will be treated with skin-sparing
IMRT
- Patients may not be concurrently
enrolled in a protocol that involves treatment of
the skin, i.e., applying lotions/moisturizers
- Protocols that do not involve treatment of the
skin are allowed

Ductal_carci
noma
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